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CHAPTER I 
 
 
INTRODUCTION 
 
The advent of the polymerase chain reaction (PCR) to amplify and detect low-
abundance nucleic acid targets has been a tremendous asset to bacterial 
detection and identification, and PCR assays are commonly used in diagnostic 
assays.  Armed with little more than knowledge of the nucleic acid sequence of a 
particular pathogen an assay can quickly be designed to detect the organism.  
DNA sequencing technology had developed at a tremendous rate, and 
sequencing of entire genomes is now fairly routine.  However, in the case of 
poorly characterized or newly emerging and often threatening pathogens, 
genomic information may be lacking.   In other situations pathogenicity may arise 
in an organism which previously had been of little threat to health.  There is a 
need for a fairly rapid method to effectively compare genomes and identify 
potential disease markers, and to be able to detect emerging pathogens 
efficiently. 
 
Although a number of advancements in rapid, portable PCR-based detection 
systems have been made, it remains primarily a laboratory testing tool.  Rapid, 
sensitive point-of-care diagnostics which can be used at the bedside or in a
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physician’s office are in high demand.  In addition, sometimes it is desirable to 
detect protein rather than nucleic acid targets, especially when the phenotypic 
trait is closely linked to pathogenicity of an organism.  Traditional immunoassays 
remain a highly effective tool for identification of protein targets, particularly when 
coupled with sensitive assay methods such as fluorometry.  However, detection 
which relies on traditional fluorescent immunoassay methods is a multi-step 
process which is time- and labor-intensive, typically requiring multiple antibodies 
for maximum sensitivity.  As a result these tests are normally performed in a 
diagnostic laboratory environment and are not easily performed as a point-of-
care diagnostic.  Coupling sensitive fluorescent protein detection with assay 
portability has been a challenge. 
 
Ideally the best system to effectively detect and identify bacterial pathogens 
should be highly sensitive, fast, easily performed with a minimum of training, and 
unencumbered by the need for additional reagents.  Rapid, label-free detection 
methods are of great interest in medical diagnostics, biodefense and food safety.   
 
The work described in this dissertation strives to address all the aforementioned 
points, tied together under the common theme of detection and identification of 
pathogenic bacteria: 
1. Suppression subtractive hybridization is employed to identify genetic 
markers unique to Clostridium piliforme, an essentially uncharacterized 
pathogen of great importance in animal health, and to laboratory animals 
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in particular, with the goal of identifying markers tied to production of 
cytotoxic factors. 
2. Development of a rapid, amplified fluorescent assay to detect low-affinity 
penicillin binding protein, PBP2a, the protein responsible for the antibiotic-
resistant phenotype associated with methicillin-resistant Staphylococcus 
aureus, a serious human and animal pathogen. 
3. Development of a label-free optical method using microring resonator 
technology to detect whole Salmonella Typhimurium and Escherichia coli 
O157:H7 bacterial cells.  These are both major foodborne disease 
pathogens, and demonstrate applicability of the assay to a multiplex 
detection platform. 
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CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
 
Clostridium piliforme and Tyzzer’s Disease 
 
Clostridium piliforme was originally identified by Tyzzer (1917) as the causative 
organism involved in fatal necrotic hepatitis in rodents.  It is a large (30-40 µm) 
rod-shaped, motile, spore-forming organism, existing in the vegetative state as 
an obligate intracellular pathogen in infected host cells.  Originally named 
Bacillus piliformis, the organism has been reclassified as a Clostridium species 
based on phylogenetic grouping from 16S ribosomal RNA (rRNA) sequence 
analysis (Duncan et al., 1993).  C. piliforme is the causative agent of Tyzzer’s 
disease, an often fatal enterohepatic disease which affects a wide range of 
animal species.  The organism is difficult to culture owing to its obligate 
intracellular nature, and is propagated in vitro in host cell or egg cultures, or in 
vivo in laboratory rodent hosts.  Isolates have been obtained from natural 
infections, and individual isolates differ substantially in host toxicity and host 
range.  
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Tyzzer’s Disease 
Tyzzer’s disease occurs most often in rodent species as well as rabbits and 
hares, and it is a significant laboratory animal disease.  After rodents, the next 
most common occurrence of the disease is in horses, and in both mice and 
horses clinical symptoms of the disease are usually associated with young 
animals, from birth to weanling stage (Harrington, 1975; Whitwell, 1976; 
Harrington, 1976; Turk et al., 1981; Fosgate et al., 2002).  The disease has also 
been reported in cattle (Webb et al., 1987), deer (Brooks et al., 2006), dogs 
(Boschert et al., 1988; Young et al., 1995), coyotes (Marler et al., 1976), snow 
leopards (Schmidt et al., 1984), muskrats (Chalmers et al., 1977), grey foxes 
(Stanley et al., 1978), red panda (Langan et al., 2000), raccoon (Wojcinski et al., 
1986), and marsupials (Canfield et al., 1991).  The disease has also been 
reported in avian species (Raymond et al., 2001; Saunders et al., 1993), and 
isolated occurrences in humans (Smith et al., 1996) and tamarins (Sasseville et 
al., 2007) have also been reported. 
 
There appear to be 2 forms of the disease:  An acute, often fatal clinical form and 
a latent subacute form associated with asymptomatic carriers of the C. piliforme 
pathogen.  In the acute form of the disease clinical symptoms may include 
lethargy, edema and diarrhea, although onset of the disease is rapid with death 
usually occurring within 24 hours, and frequently animals are found dead with no 
other clinical indicators.  The disease is characterized by pronounced 
hepatomegaly, multifocal lesions of hepatic necrosis, and acute hepatitis, and 
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cytological examination of infected tissue reveals the presence of intracellular C. 
piliforme bacteria, often arranged in bundles within host cells (Fujiwara et al., 
1978; Ganaway et al., 1971; Franklin et al., 1993).  In the subacute form there 
are no clinical signs and animals appear healthy.  In laboratory animals, stress or 
immunocompromization may trigger transition to the fatal acute form (van Andel 
et al., 1997; van Andel et al., 1998).  In adult animals the organism may establish 
itself as part of the normal gut flora, and transmission of the disease may occur 
as a result of fecal-oral transmission of spores to susceptible individuals (Motzel 
and Riley, 1992).  After spore ingestion the exact method of hepatic colonization 
is unknown. However, based on histological evidence there appears to be initial 
infection within the small and large intestine and cecum, with dissemination to the 
liver (Ganaway, 1971).  Franklin et al. (1993) presented an in vitro model of 
invasion which suggests that phagocytic processes are involved, and direct cell-
to-cell spreading of the organism is a key factor, since C. piliforme infectivity 
diminishes rapidly following release from infected cells. 
 
There is considerable variability among C. piliforme isolates with regard to 
infectivity, preferred hosts and cytotoxic activity.  Experimental inoculation of 
different animal species with isolates derived from naturally occurring hamster 
(H2), rat (R1) and mouse (M1) infections resulted in no infection in rats or mice 
using any of the isolates tested, while hamsters succumbed to the disease 
following inoculation with the H2 isolate.  However, in rats and mice infected with 
R1 and M1 cultures, respectively, there was a significant immune response 
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(Franklin et al., 1994).  Serological surveys of horses in 4 Midwestern states 
using isolate-specific monoclonal immunoassays indicated that of 162 samples 
tested, 37 had a significant immunoresponse to equine isolate while 23 tested 
were seropositive for antibodies to a rat isolate, implying multiple strains were 
capable of infecting horses (Hook et al., 1995).  Differences in antigenicity (Boivin 
et al., 1993) and expressed protein profiles (Riley et al., 1990) in various isolates 
has been demonstrated, and may play a major role in infectivity and host range.  
Notable differences in cytotoxicity of various isolates have also been reported 
(Riley et al., 1992).  Culture filtrates of seven isolates were added to mouse or rat 
cell cultures and toxigenic effects were observed.  Of the seven filtrates tested, 
four demonstrated cytotoxic effects when added to cell cultures (rabbit, guinea 
pig, gerbil and hamster), although cytotoxicity tended to be dependent upon cell 
line.  Isolates which had no cytotoxicity included mouse, rat and horse.  Testing 
of size-fractionated filtrates suggested the factor(s) responsible for increased 
cytotoxicity were proteins or protein complexes with molecular weight greater 
then 100 kDa.  It was postulated that production of cytotoxic factors was in part 
responsible for the increased incidence of acute Tyzzer’s disease associated 
with cytotoxin-producing isolates. 
 
Detection of C. piliforme 
Early diagnoses of Tyzzer’s disease relied on post-mortem examination of 
affected tissues, and microscopic visualization of lesion-associated C. piliforme 
served as positive confirmation of the disease.  Motzel and Riley (1991) 
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developed an enzyme-linked immunosorbent assay (ELISA) for detection of 
serum antibodies to C. piliforme, and a screening and diagnosis tool based on 
immunoassay was described by Hansen et al. (1994).  Isolate-specific 
competitive immunoassays have also been developed (Boivin et al., 1994).  Goto 
and Itoh (1994) described a polymerase chain reaction (PCR) test to detect the 
presence of C. piliforme rDNA by amplification of specific sequences associated 
with C.piliforme 16S rRNA in heart and liver samples from infected animals.  
PCR-based disease confirmation in horses has also been reported (Borchers et 
al., 2006).  Furukawa et al. (2002) demonstrated successful amplification of C. 
piliforme 16S targets from spiked fecal samples.  Additional amplification studies 
using 23S and 16S ribosomal targets have allowed a small degree of isolate-
specific detection (Feldman et al., 2006).  Immunoassay is still regarded as a 
fundamental screening tool for the presence of C. piliforme, with confirmatory 
testing using PCR or microscopic examination (Otto and Franklin, 2006).  
However, commercial services for screening fecal samples for presence of the 
organism by 16S ribosomal analysis are available (www.zoologix.com).  To date 
the organism is poorly characterized genetically, and no practical isolate-specific 
DNA tests have been reported. 
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Methicillin-Resistant Staphylococcus aureus 
 
Importance In Human Health 
Methicillin-resistant Staphylococcus aureus (MRSA) represents a serious, 
worldwide health threat.  In 2005 in the U.S. alone, invasive MRSA infections 
were estimated to be 94,360, with 18,650 deaths associated with MRSA (Klevins 
et al., 2007).  The threat continues to increase.  According to the Centers for 
Disease Control (CDC) the number of staphylococcal infections attributable to 
MRSA were only 2% in 1974, rising to 22% in 1995 and 63% in 2004 (Centers for 
Disease Control and Prevention (October 17, 2007), "MRSA: Methicillin-resistant 
Staphylococcus aureus in Healthcare Settings”).  The majority of infections are 
associated with healthcare settings, particularly nosocomial infections involving 
hospital- (or health care-) associated MRSA (HA-MRSA), although the number of 
community-associated MRSA (CA-MRSA) is rising rapidly.  Proper choice of 
antibiotic therapy is of great importance, as increased use of antibiotics is 
implicated as a causative factor in promotion of resistance.  Moreover, 
inappropriate use of antibiotics appears to drive increased pathogenicity at 
molecular and cellular levels, promoting emergence of new resistant strains.  
These changes include activation or modification of quorum sensing, altered 
production of staphylococcal toxins, changes associated with induction of 
bacterial SOS responses, and changes in ability of bacteria to adhere to and 
colonize host tissues (Dancer, 2008). 
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Methicillin was developed as a penicillinase-resistant antibiotic in 1959, and by 
1961, the first MRSA strain was isolated in the United Kingdom (Jevons, 1961).  
Resistance to the drug is provided by a low-affinity penicillin binding protein 
(PBP2a or PBP2’) which is capable of continued cell wall synthesis in the 
presence of methicillin and oxacillin, effectively replacing the function of proteins 
with higher binding affinity found in methicillin-sensitive S. aureus (MSSA) which 
are inactivated by irreversible binding of the antibiotic (Giesbrecht et al., 1998).  
The PBP2a protein is a product of the mecA gene, which is part of a larger 
mobile genetic element called the staphylococcal cassette chromosome mec 
(SCCmec). 
 
HA-MRSA, CA-MRSA and SCCmec 
There are five main types of SCCmec (I-V).  SCCmec types I, IV and V are 
responsible only for resistance to ß-lactam antibiotics, while types II and III drive 
multidrug resistance.  Resistance to drugs other than ß-lactams is conferred by 
additional integrated plasmids or transposons, and includes resistance to 
kanamycin, tobramycin, bleomycin, penicillins, heavy metals, macrolides, 
lincosamides and streptogramins (Duerenberg et al., 2007).  HA-MRSA is 
associated with SCCmec types I, II and III.  Multidrug resistance is not commonly 
associated with CA-MRSA strains, which predominantly carry the SCCmec types 
IV and V, in addition to a potent pore-forming exotoxin, the Panton-Valentine 
leukotoxin (PVL) (de Lencastre et al., 2007; Duerenberg et al., 2007).  PVL is not 
carried on SCCmec, but instead is the product of a phage-encoded genetic 
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element.  The toxin is associated with necrotizing pneumonia, skin and soft 
tissue infections and necrotizing fasciitis (Boyle-Vavra and Daum, 2007; Lina et 
al., 1999).  There is evidence to indicate that CA-MRSA is derived from CA-
MSSA which acquired a mobile SCCmec methicillin resistance element rather 
than a PVL-containing variant of HA-MRSA (Feng et al., 2008; Boyle-Vavra and 
Daum, 2007).  However, clear distinctions between HA-MRSA and CA-MRSA 
are becoming more difficult to establish, as more HA-MRSA infection is 
becoming spread throughout the community as result of delayed infection after 
leaving the hospital setting.  Definitions of MRSA infections have therefore been 
revised to reflect healthcare-associated infection with either community onset or 
hospital onset (appearing >48 hours after admission) subgroups, and community-
associated MRSA (Klevins et al., 2007).   
 
mecA Gene 
The mecA gene codes for the PBP2a protein, the phenotypic determinant of 
methicillin resistance, and is carried on the SCCmec element along with genes 
for regulators of protein expression from the mecA locus, mecI and mecR1.  
MecR1 is a ß-lactam-sensing transmembrane receptor/transducer element, while 
MecI acts as a repressor of PBP2a expression from mecA.  Binding of inducer to 
the receptor triggers activation of an intracellular protease domain which cleaves 
the repressor and activates expression from mecA and mecR1-mecI.  MecI 
shares considerable homology to BlaI, the repressor associated with production 
of staphylococcal penicillinase, and both proteins can function as repressors for 
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the mecA and blaZ genes (Lewis and Dyke, 2000).  However, MecR1 and BlaR1 
are specific for their cognate repressors and cannot act interchangeably 
(McKinney et al., 2001).  Methicillin and oxacillin are poorly sensed by the MecR1 
transducer, and induction is slow in the presence of these antibiotics.  Thus, 
strains which carry the mecA gene may appear phenotypically susceptible.  
However, under antibiotic pressure inactivation or deletion of mecI or promoter 
mutations occur which results in constitutive expression of PBP2a and the fully 
resistant phenotype (Rohrer et al., 2003; Berger-Bachi and Rohrer, 2002; 
Hiramatsu et al,.1996). 
 
PBP2a Protein 
Cell wall synthesis in S. aureus requires transpeptidation to achieve a high 
degree of peptidoglycan crosslinking, an activity provided by 4 membrane-
anchored proteins, termed penicillin binding proteins 1-4 (PBP1-PBP4) 
(Chambers, 1997).  These proteins are deactivated by irreversible binding of ß-
lactams via acyl-enzyme-antibiotic complex formation within the active site of the 
transpeptidase domain, resulting in inhibition of cell wall synthesis and 
termination of cell growth and division (Giesbrecht et al., 1998).  The mecA gene 
codes for a 76 kDa membrane-associated penicillin binding protein, PBP2a, with 
low affinity for ß-lactam antibiotics, and in the presence of these agents remains 
capable of transpeptidase activity (Hartman and Tomasz, 1984).  A combination 
of decreased acylation rate and low affinity with regard to pre-acylation 
complexes is responsible for the decreased affinity which allows the enzyme to 
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maintain function (Fuda et al., 2004).  However, transpeptidase activity is 
primarily confined to forming muropeptide dimers when all other PBPs are 
deactivated by antibiotic binding (deJonge and Tomasz, 1993).  Nonetheless, 
sufficient activity remains to facilitate growth in the presence of methicillin or 
oxacillin and yield the fully resistant MRSA phenotype.  Structurally, the PBP2a 
protein contains an N-terminal hydrophobic membrane-spanning domain with an 
adjacent region believed to be a transglycosylase domain, with a C-terminal 
transpeptidase domain.  Interestingly, the transglycosylase domain appears to 
have little functional activity, as PBP2a has been shown to be dependent on 
transglycosylation activity provided by the it’s high-affinity PBP2 counterpart 
(Pinho et al., 2001). 
 
The transmembrane domain imparts considerable hydrophobicity to the PBP2a 
protein, and water-soluble forms of the protein have been created by deletion of 
the N-terminal anchoring sequence (Fuda et al., 2004; Wu et al., 1992).  These 
recombinant forms appear to be functionally similar to the native proteins, and 
have been used for kinetic antibody binding studies and to study the mechanism 
of antibiotic resistance in PBP2a (Fuda et al., 2004). 
 
Detection of MRSA 
Traditional testing for antibiotic-resistant bacteria has utilized growth inhibition 
assays such as agar disc diffusion or broth microdilution.  However, these 
methods are time-consuming and labor-intensive, sometimes requiring days 
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before confirmation of MRSA infection.  Additional complications are introduced 
due to heterogeneous expression of PBP2a in mixed bacterial populations in 
clinical samples, resulting in a wide range of observed minimum inhibitory 
concentrations (MIC) values (Chambers, 1997; Sabath et al., 1972).  Additional 
challenges are presented by borderline resistant cultures (BORSA), which can be 
classified into 2 groups – those which have the mecA gene in a very small 
resistant subpopulation, which can grow at high drug concentrations, and those 
which lack mecA and low-level resistance is due to overexpression of ß-
lactamase or other factors (Chambers, 1997).  In each of these cases it may be 
necessary to induce high-level expression by culture in the presence of antibiotic 
to make accurate determination of MRSA, although reversion to a heterogeneous 
phenotype is common upon additional culture in antibiotic-free medium.  In 
addition, heteroresistant cultures tend to grow more slowly, and culture at 
reduced temperatures is recommended to ensure accurate identification, and 
screening by plating on oxacillin-containing medium at lower incubation 
temperatures is recommended. 
 
Disc diffusion susceptibility testing using cefatoxin has proven to be much better 
than oxacillin (reviewed by Appelbaum, 2007) and this method, as well as 
selective growth on oxacillin-containing medium, are recommended as growth-
based screening methods for MRSA by the Clinical and Laboratory Standards 
Institute (CLSI; formerly the National Committee for Clinical Laboratory 
Standards).  New growth-based methods based on chromogenic detection have 
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also been developed (for review see Malhotra-Kumar et al., 2008) which allow 
simultaneous determination of antibiotic resistance (primarily by inclusion of 
antibiotic in test medium) and positive identification of S. aureus by production of 
insoluble colored products, giving rise to colonies with distinct colors which are 
easily distinguishable.  There are a variety of commercially-available products of 
this type, and some are capable of producing results within 24 hours.  Recently 
Brown et al. (2005) published suggested guidelines for laboratory diagnosis and 
susceptibility testing of MRSA.  The publication includes an expanded list of 
testing methodology and procedures, as well as growth characteristics 
associated with a variety of screening media. 
  
In the case of clinical presentation of the disease, application of effective 
antibiotic therapy is extremely time-sensitive and cannot be delayed while 
awaiting laboratory results.  In these cases treatment is often started 
immediately, sometimes using “last line of defense” drugs like vancomycin, while 
awaiting laboratory results.  However, inappropriate use of these antibiotics 
fosters undesirable development of resistance to these drugs and emergence of 
resistant strains, which may pose a much larger health threat (Dancer, 2008).  
Therefore, rapid tests to accurately identify MRSA are highly desirable.  In 
addition, the potential to deploy these tests in a hospital admission protocol, to 
allow screening of infected individuals so that proper isolation precautions can be 
taken, is very appealing. 
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There are several recent reviews pertaining to development and current status of 
rapid diagnostics for bacterial infections (Tenover, 2007; Barken et al., 2007) , 
and in particular rapid detection of MRSA (Malhotra-Kumar et al., 2008; Carroll, 
2008).  Virtually all of these tests utilize the power of the polymerase chain 
reaction (PCR) to amplify target nucleic acid sequences to enable fast, accurate 
detection with a minimum of culture time, particularly when modern rapid blood 
culture systems are used.  The tests are typically performed using real-time PCR 
equipment which allows integrated detection of products via fluorescent signal 
generation.  Some assays amplify and detect the mecA gene individually or in 
multiplex with other S. aureus targets, including the lukS-lucF genes encoding 
PVL associated with CA-MRSA.  One notable exception, which has received 
FDA approval, is the IDI-MRSA (a.k.a, GeneOhm MRSA, BD Biosciences) which 
targets an amplicon spanning the terminal end of SCCmec and includes a portion 
of the adjacent S. aureus-specific orfX gene, allowing simultaneous identification 
of S. aureus and presence of SCCmec.  The system has been proven effective 
for detection of MRSA from a variety of clinical samples including direct detection 
from nasal, perineum and throat swabs.  Another FDA-approved assay using 
similar technology, the GeneXpert MRSA assay (Cepheid), is capable of 
generating results within 75 minutes with a minimum of sample preparation and 
technical expertise required (Malhotra-Kumar et al., 2008).  A new highly 
multiplexed fluorescent assay system has also been developed:The Staphplex 
system (Genaco Biomedical Products) is capable of performing simultaneous 
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PCR on 17 targets with characterization of individual products based on 
Luminex® multicolor fluorescent bead technology (Malhotra-Kumar et al., 2008). 
 
All of the aforementioned rapid assays target genetic elements for identification 
of MRSA.  However, the true determinant of the MRSA phenotype is the 
expression of PBP2a protein, and some strains which carry SCCmec may lack 
expression of PBP2a (see above), and are phenotypically MSSA.  Testing of 
these strains using genomic assays would yield a false positive result, although 
an argument could be made that these strains are “poised” to jump toward the 
MRSA phenotype.  Rapid assay development for protein detection has been 
limited because protein targets cannot be amplified as is routinely done with 
genetic targets.  The standard method currently used for detection of PBP2a, and 
the method approved by CLSI, involves the agglutination of antibody-
functionalized latex beads (Nakatomi and Sugiyama, 1998).  Several of these 
assays are available commercially (e.g., MASTALEX-MRSA™ (Mast Group); 
Staphaurex Plus (Oxoid, LTD.); MRSA Latex Test (Denka Seiken)), and utilize 
monoclonal antibody to PBP2a attached to latex beads.  Cells are lysed and 
mixed with beads, and if MRSA are present, visible agglutination occurs.  The 
process requires a large number of cells from a colony grown on a plate, to work 
effectively.  Although the test is fairly rapid, on the order of several minutes, the 
preparation time (culture growth) precludes the use of these products as true 
rapid assays.  However, the latex agglutination assay is considered a gold 
standard for testing MRSA based on PBP2a expression. 
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Foodborne Enteric Pathogens: Salmonella 
and Escherichia coli O157:H7 
 
 
Organism Significance 
In the U.S. each year it is estimated that 76 million people are affected by food- 
and water-borne illnesses, resulting in 325,000 hospitalizations and 5,000 deaths 
(Mead et al., 1999).  Of the bacterial organisms associated with foodborne 
illness, the most prevalent are enterohemorrhagic E. coli, particularly serovar 
O157:H7, and Salmonella enterica serotypes including serotype Typhimurium 
(old nomenclature S. typhimurium).  According to the World Health Organization, 
between 200 million and 3 billion cases of intestinal disease are associated with 
non-typhoidal Salmonella infections each year, with an estimated 3 million deaths 
(World Health Organization, 2005).  Both Salmonella and E. coli are considered 
major foodborne pathogens and, in addition to medical costs associated with 
Salmonella and E. coli infections there is a large burden on food producers as 
well.  E. coli O157:H7 is now considered a food adulterant, and products 
containing E. coli O157:H7 are considered unfit for consumption.  Recent 
outbreaks of foodborne illness associated with E. coli include a multi-state 
incident in 2006 involving fresh spinach, that resulted in 199 reported cases with 
16% developing hemolytic-uremic syndrome (HUS), and 3 confirmed deaths.  A 
more recent outbreak in 2007 involving contaminated beef patties resulted in the 
recall of 21.7 million pounds of suspect product, ultimately forcing the supplier 
out of business (Nugen and Baeumner, 2008).  Most recently (June, 2008) a 
 19 
widespread outbreak of Salmonella associated with tainted tomatoes has 
resulted in 756 people infected across 34 states and the District of Columbia 
(CDC, 2008). 
 
The possibility of using these organisms as terrorist weapons to poison food 
distribution chains or water reservoirs has been recognized (Sobel et al., 2002a; 
Sobel et al., 2002b). Centralized processing and delivery facilities that prepare 
and ship food items to different parts of the country and beyond are especially 
vulnerable to such attacks.  Salmonella Typhimurium is one of the few organisms 
in recent history that has been employed for deliberate contamination of food. An 
incident of intentional Salmonella Typhimurium contamination of salad bars in 
Oregon (1984) resulted in 751 people developing salmonellosis (Torok et al., 
1997).   In addition, E. coli O157:H7 has been identified as one of the most likely 
Category B organisms posing a bioterrorist threat (US Dept. Health Hum. Serv. 
et al., 2006). 
 
E. coli O157:H7 
E. coli infections result from the consumption of contaminated food, mainly 
undercooked meat, unpasteurized milk or juice, and fresh vegetables (Goldman, 
2006).  Infection can also be acquired by contact with contaminated water and 
can be spread from person to person.  The organism is a common inhabitant of 
the ruminant digestive tract, and ruminants are considered a large natural 
reservoir for the bacteria (Gyles, 2007).  E. coli associated with disease is 
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classified into broad groups based on their mode of pathogenesis:  
Enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroinvasive 
E. coli (EIEC), and enterohemorrhagic E. coli (EHEC), also called Shiga toxin-
producing E. coli (STEC).  The hallmark of STEC is the production of the Shiga 
toxin Stx (consisting of 2 subgroups, Stx1 and Stx2).  Of the EHEC serotypes 
O157:H7 is one of the most virulent, with infectious human dose believed to be 
less than 100 bacteria (Deisingh and Thompson, 2004). 
 
Early clinical symptoms are abdominal cramping and watery diarrhea, later 
turning to bloody diarrhea.  In severe cases patients can suffer hemolytic-uremic 
syndrome (HUS) as a result of bacterial production of Stx toxin in the colon.  Stx 
acts in the kidney by damaging renal cells and occluding microvasculature 
resulting in renal inflammation and possibly fatal acute renal failure (Kaper et al, 
2004).  Typical treatment of E. coli O157:H7 infection is primarily supportive, and 
antibiotic therapy is not recommended due to the potential to induce HUS (Karch 
et al., 2005).  Confirmatory diagnosis relies primarily on culture of the organism 
from stool samples, sometimes supported by immunoassays such as latex 
agglutination. 
 
Salmonella 
The genus Salmonella is comprised of 2 major species containing over 2500 
different serovars.  Some S. enterica serovars are associated with typhoid (S. 
Typhi), while most serovars cause enterocolitis and diarrhea in humans (Coburn 
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et al., 2007).  Symptoms associated with Salmonella-induced enterocolitis are 
similar to those found in EHEC infections, namely abdominal cramps and 
diarrhea which may become bloody.  Unlike EHEC, Salmonella infectious dose is 
much higher (greater than 50,000 bacteria), and onset of symptoms is usually 
more rapid and may involve fever.  Also unlike EHEC, Salmonella is an 
intracellular pathogen which survives in intracellular vacuoles following 
phagocytosis, and the organism has developed a wide range of virulence factors 
to enhance host colonization (Coburn et al., 2007).  Laboratory confirmation of 
Salmonella infection is primarily by culture of stool samples on selective medium.  
 
In contrast to clinical testing, the needs for testing food products are more 
demanding, requiring high sensitivity to accurately detect E. coli and Salmonella.  
Methods for detection of E. coli O157:H7 have been reviewed by Deisingh and 
Thompson (2004a), and include conventional culture methods on selective 
medium, sometimes with a pre-enrichment step such as immunomagnetic 
collection to enhance sensitivity.  Immunological detection methods such as 
ELISA or immunofluorescence are also used, but maximum sensitivity is usually 
attained using PCR methodology, including real-time PCR.  However, these 
methods are laborious and time-consuming, and there is great interest in the 
development of biosensors to allow rapid detection of foodborne pathogens.  
Sensor platforms developed for food applications also have the potential to be 
employed for clinical diagnosis applications.  Of particular interest are rapid, 
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label-free assays which require minimum effort, no additional reagents and which 
can achieve the desired result in a much shorter time period. 
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Non-Optical Label-Free Biosensor Platforms 
 
Electrochemical Methods 
Electrochemical detection methods rely on the interaction of analyte with 
electrodes in an assay cell.  Sensing of biomolecules may use a variety of 
electrical measurement techniques including voltammetry, conductivity, 
capacitance, potentiometry and impedance, and the reader is directed toward 
recent comprehensive reviews describing the principles and methods of 
electrochemical biosensing for proteins, amino acids and peptides (Lambrianou 
et al., 2008; Herzog and Arrigan, 2007; Yu et al., 2006) and DNA (Lucarelli et al., 
2008; Odenthal and Gooding, 2007).  Electrochemical methods have also been 
used for detection of pathogenic bacteria, and electrochemical impedance 
methods are routinely used to monitor growth of cells in culture (impedance 
microbiology, for review see Yang and Bashir, 2008).  Of particular interest is the 
use of electrical impedance for the development of sensors to specifically detect 
food pathogens.  These devices use electrical impedance spectroscopy (EIS) to 
detect binding of cells to electrodes functionalized with antibodies to specific 
bacteria.  Binding of bacteria results in increased impedance between electrodes 
in an electrical cell due to the insulating properties of bacterial cell membranes, 
which effectively blocks electrode surfaces.  Presence of bacteria is determined 
by a change in current or change in electrical impedance measured as a function 
of interrogating frequency (Yang and Bashir, 2008; Maalouf et al., 2007).  Label-
free detection is realized by use of interdigitating electrodes with small electrical 
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gaps (~15 um), and has been used to detect the presence of viable Salmonella 
typhimurium and E. coli O157:H7, with a limit of detection of ~106 CFU/ml (Yang, 
2008; Yang et al., 2004). 
 
Surface Acoustic Wave (SAW) Sensors 
Principle of operation, types of SAW sensors, and the sensors’ use in biological 
sensing applications has been recently reviewed (Cooper and Singleton, 2007; 
Gronewold, 2007).  SAW devices utilize piezoelectric materials such as quartz to 
generate an acoustic wave (SAW) which propagates down the length of the 
sensor.  SAW sensors have multiple layers, the composition and thickness 
depending upon the type of wave form desired (e.g., Love wave sensors).  In all 
cases, the acoustic wave, which is typically produced by electrical excitation of 
the piezoelectric material, is carried in a guide layer on the surface of the 
piezoelectric substrate and has a defined velocity and amplitude.  Interaction with 
the surface (such as during a binding event) affects the velocity/amplitude of the 
acoustic wave.  SAW sensors have been used for a wide range of biosensing 
applications including protein interactions, DNA hybridization, kinetic binding 
assays and whole cell and bacterial detection.  Branch and Brozik (2004) 
demonstrated the utility of specially-designed Love wave sensors by immobilized 
antibody-mediated binding of Bacillus spores.  Recently, Moll et al. (2007) 
described the use of a Love wave device for detection of E. coli with a detection 
limit of ~106 bacteria/ml.  However, successful detection was dependent upon 
binding of E. coli through a 2-antibody “sandwich” strategy. 
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Quartz crystal microbalances (QCMs) are another type of acoustic wave sensor.  
In comparison to Love wave-type sensors, QCMs are generally bulk wave 
sensors, where the wave is propagated throughout the substrate.  For a detailed 
examination of bulk wave sensor design and materials used to create them, as 
well as the use of these devices in biosensing applications, the reader is referred 
to the comprehensive review of Cooper and Singleton (2007).  These types of 
sensors have been also been used for a wide range of biosensing applications 
including detection of proteins and nucleic acids, whole cell detection, etc.(see 
Cooper and Singleton, 2007; Gronewold, 2007; Deisingh and Thompson, 2004b; 
Cooper, 2003).  As acoustic mass transducers, they are attractive for detection of 
whole bacterial cells and have been used for sensitive detection of Salmonella 
(Huang and Cooper, 2006; Olsen et al., 2003; Pathirana et al., 2000) and E. coli 
(Huang and Cooper, 2006; Serra et al., 2008; Wang et al., 2008; Berkenpas et 
al., 2006) with effective linear bacterial detection range from 102-108 CFU/ml.  
 
Microcantilever/Cantilever Devices 
Cantilever-type devices have been recently reviewed by Waggoner and 
Craighead (2007).  They function primarily as bound mass sensors, and the 
principles of operation are derived from their atomic force microscopy (AFM) 
origin.  They are classified as micro- or nanoelectromechanical systems (MEMS 
or NEMS, respectively), and can be operated in static or resonance mode.  
Similar to SAW devices, they take the general form of a sensing region 
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connected to a support by means of a flexible beam structure, and are fabricated 
from single or multiple layers of materials in sizes ranging from hundreds of 
nanometers to millimeters (as in the case of cantilever devices).  An example of a 
microcantilever device is shown in Figure 3.  In the static mode, binding of mass 
to the sensor surface induces a deflection in the beam which is measured 
optically or electronically.  In resonance mode, cantilever devices may be excited 
by simple thermal energy, via electrical input or by coupling to piezoelectric 
materials, and changes in resonant state as a function of increasing bound mass 
can be determined optically or electronically (Waggoner and Craighead, 2007; 
Hansen and Thundat, 2005). 
 
Deflection-based sensors have been used as label-free biosensors to detect 
protein binding, DNA hybridization and binding of whole bacterial cells or spores 
to the sensor surface (Waggoner and Craighead, 2007).  Bacillus endospores 
were detected in liquid at a concentration of 5 x 107 spores/ml (Dhayal et al., 
2006).  Using microcantilevers functionalized with antibodies to Salmonella, 
Weeks et al. (2003) claimed detection sensitivity as low as 25 bacterial cells 
bound to the sensor surface.  Detection of E. coli O157:H7 was also 
demonstrated using an antibody-functionalized, deflection mode sensor, although 
substantially higher detection limits (1 x 106 CFU/ml) were reported (Zhang and 
Ji, 2004).  However, in most cases deflection measurements must be performed 
in air using a dried, normalized sensor surface, and real-time detection using 
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these devices is generally not feasible (Waggoner and Craighead, 2007; Dhayal 
et al., 2006; Yu et al., 2006; Hansen and Thundat, 2005). 
 
In comparison to deflection-based devices, resonance-mode microcantilever 
designs have seen wider use in biosensing applications, and in some cases a 
device can be employed in both modes (Waggoner and Craighead, 2007; 
Hansen and Thundat, 2005).  For resonance mode devices, mass sensitivity is a 
function of quality factor, or Q, which is defined as: 
1
0
−
∆= fwhmffQ , 
where 0f  is the resonant frequency and fwhmf∆  is the full-width at half maximum 
of the resonance peak.  Thus, narrow and well defined peaks will have higher Q 
values associated with them, and very small shifts in resonant frequencies can 
be discriminated (Waggoner and Craighead, 2007).  By decreasing sensor mass 
and increasing Q factors, extremely high sensitivity to bound mass can be 
achieved, to the attogram (Ekinci et al., 2004; Ilic et al., 2004) or even zeptogram 
(Yang et al., 2006) level. 
 
Binding and detection of E. coli O157:H7 cells to a resonance device was 
demonstrated by Ilic et al. (2000).  Unfortunately, utility of these devices for 
detection in liquid samples, particularly in real-time, has been limited due to 
damping forces of liquid medium on the cantilever surface.  However, recent 
work using millimeter-sized cantilevers and devices fabricated from new 
composites have demonstrated the ability to detect Salmonella (Zhu et al., 
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2007a; Zhu et al., 2007b) and E. coli O157:H7cells (Campbell and Mutharasan, 
2007; Campbell et al., 2007; Campbell and Mutharasan, 2005a; Campbell and 
Mutharasan, 2005b; Maraldo and Mutharasan, 2007) in liquid, with detection 
limits of 500 cells/ml for Salmonella (Zhu et al., 2007b) and 700 cells/ml for E. 
coli (Campbell and Mutharasan, 2005b).  
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Optical Label-Free Biosensor Platforms 
 
Surface Plasmon Resonance (SPR) 
Surface plasmon resonance is an optical method for determining interactions 
(binding events) occurring at a sensor surface, wherein changes in bound mass 
are manifested as changes in refractive index (RI).  The principle of SPR and the 
relationship to biosensing applications has been presented in several reviews 
(Ricci et al., 2007; Cooper, 2003; Homola, 2003; Homola, 1999).  A basic 
overview of SPR is presented to allow understanding of how SPR biosensors 
function and for comparison to other optical biosensing methods.  SPR is based 
on the transfer of light energy (photons) to electrons in a metal film.  When 
polarized light passes through a prism or grating and strikes a thin metal film 
(gold for example) which is bordered by a dielectric layer, oscillations in free 
electrons, or surface plasmons, are generated in the metal layer and are 
propagated parallel to the dielectric layer.  The result is generation of an 
electromagnetic field, or evanescent wave, with maximum charge density at the 
metal-dielectric interface, and which decays exponentially with distance from the 
metal surface to a maximum decay length of about 200 nm from the metal layer.  
SPR is extremely sensitive to changes in refractive index associated with the 
dielectric layer and within the evanescent field caused by adsorption or 
desorption of molecules from the surface.  The refractive index is detected by 
monitoring the angle of light reflected from the back of the thin metal film.  When 
photon and plasmon energies are equal there is coupling into the dielectric layer, 
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which is detected as a dip or “shadow” at a specific angle of reflection.  SPR is 
sensitive to any mass within the evanescent field, whether bound or unbound, 
and for this reason assays are typically performed under constant flow conditions 
so that only specific binding events are detected.  When refractive index changes 
as a result of surface binding events the angle shifts slightly, and the resulting 
shift in SPR dip can be plotted as a function of time (a sensorgram) (Figure 4) 
(Yu et al., 2006; Cooper, 2003; Homola, 2003).   
 
SPR has been utilized for a wide range of biosensing applications from small 
molecules such as drugs and metabolites to larger targets including proteins, 
toxins, antibodies and whole cells (for examples see Homola, 2008; Ricci et al., 
2007; Homola, 2003).  Typically, immobilization of antibodies on the sensor 
surface confers target specificity, and localized mass increases as a result of 
ligand binding drive refractive index changes.  Of particular interest is the 
detection of whole bacterial cells, particularly those associated with foodborne 
illness.  Although SPR is a relatively new method, a number of experimental 
reports associated with foodborne or enteric pathogen detection have been 
published.  Detection of E. coli O157:H7 from culture dilutions was demonstrated 
using a direct assay involving binding of whole cells to immobilized anti-E. coli 
antibodies, with a detection limit of 106 CFU/ml.  Addition of secondary antibody 
in a sandwich assay decreased the limit of detection to 104 CFU/ml 
(Subramanian et al., 2006).  Waswa et al. (2006) spiked skim milk samples with 
varying concentrations of E. coli and Salmonella and, using a direct binding 
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assay, reported sensitivities of 25 and 23 CFU/ml for E. coli and Salmonella, 
respectively, with a total assay time of less than 1 hour.  Previously, Bokken et al. 
(2003) had demonstrated high selectivity to specific Salmonella serovars using 
an SPR immunoassay, with minimum detection limit of 1.7 x 103 CFU/ml for 
Salmonella in a mixed bacterial assay sample.  Self-assembled protein G-
antibody layers on gold surfaces have been shown as highly effective methods of 
functionalizing sensor surfaces for detection of Salmonella in direct binding 
assays, with effective detection range of 102-107 CFU/ml (Oh et al., 2004a) or 
102-109 CFU/ml (Oh et al., 2004b).  Recently, similar detection limits were 
reported for Listeria monocytogenes, Campylobacter jejuni, Salmonella 
Typhimurium and E. coli species from mixed cultures using low-level (8-channel 
SPR) multiplexing for simultaneous detection of all 4 targets (Taylor et al., 2006). 
 
Microring Resonators 
Description and Principle of Operation.  Microring resonators are micron-scale 
optical devices which have seen wide use in communication circuits as optical 
switches, wavelength filters and frequency converters (Ibrahim et al., 2003; Little 
et al., 1997).  Several design formats for microring resonators have been 
reported (Ibrahim et al, 2003; Chu et al., 1999; Yanagase et al., 2002; Little et al., 
2004), with the general form being ring-shaped waveguide structures optically 
coupled to one or more linear waveguides, patterned on a planar surface (Little 
et al., 2000).  Recently they have shown utility as transducing elements for 
biosensor applications, functioning as evanescent field, refractive index sensors 
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similar to surface plasmon resonance described previously.  However, unlike 
SPR, excitation of a metal surface to generate an evanescent field is not utilized.  
Rather, in microring resonators light is coupled into a ring structure made of high 
refractive-index material via waveguides closely positioned to the resonator so as 
to allow coupling between the waveguide (light “bus”) and the ring structure 
(Figure 5).  The devices rely on total internal reflectance to guide light within the 
ring structure, taking advantage of a phenomenon called whispering gallery 
mode (WGM).  In WGM devices, light is coupled into a circular light path and 
establishes a resonance mode, travelling continuously around the path until it is 
absorbed or scattered, resulting in exceptionally long path lengths 
(Ramachandran et al., 2008; Sun et al., 2008; Yalcin et al., 2006). .WGM devices 
have been evaluated for utility in biosensing applications (Zhu et al., 2006; White 
et al., 2005; Vollmer et al., 2003; Vollmer et al., 2002).  Similar optical resonance 
patterns have been demonstrated in other devices including microcylinders and 
microdiscs (Smotrova et al., 2006; Deng et al., 2004; Zeng et al., 1999). 
 
Microring resonators employ narrow light paths such that light which is channeled 
through the resonator structure is tightly constrained, and an evanescent field 
surrounding the optical structure is generated as a result of optical boundary 
conditions defined by the microring structure (Ramachandran et al., 2008; Sun et 
al., 2008).  Conceptually, the effect could be considered similar to light “leakage” 
from the optical waveguide.  The evanescent field effect is used for optically 
coupling ring structures to input and output waveguides as well as for optical 
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sensing (Figure 5).  Microring resonators make use of high refractive index (RI) 
materials (refractive indices greater than 1.4), and optical sensing is achieved by 
functionalizing the microring surface such that specific molecular binding events 
result in an increase in bound mass within the evanescent field, in turn causing a 
change in refractive index in these areas of the structure (Ramachandran et al., 
2008; Sun et al., 2008; Yalcin et al., 2006; Ksendzov and Lin, 2005).  When 
coupled with WGM, the functionalized surface can be interrogated many times as 
light travels through the ring structure.  Optical resonance in the microring is 
attained when the condition in the following equation is satisfied, 
mR ληπ =2  
where R  is the radius of the microring, η  is the effective refractive index (RI) of 
the microring, λ  is the wavelength, and m  is any integer.  The product of the ring 
circumference ( )Rπ2  and effective RI ( )η  is termed the optical path length (OPL). 
 
Light entering the microring structure via the input waveguide of a specific 
wavelength (defined by the status of the ring structure – see equation above) 
continuously builds in phase resulting in an amplified evanescent field extending 
100-300 nm beyond the outer surface of the microring.  A small amount of light is 
coupled to the output waveguide and the resonant wavelength is analyzed.  
Changes in the evanescent field (e.g., binding events on the resonator surface) 
alter the local refractive index and, in turn, the resonance properties of the 
structure, with the end result being a shift in the wavelength of resonant light 
coupled to the output waveguide.  The shift in output wavelength is measured by 
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continuously analyzing the optical spectrum of output light (Ramachandran et al., 
2008).  The high RI of ring resonator materials imparts high Q values, on the 
order of 104, which allows generation of resonance peaks which are very narrow 
and sharp.  The Q value correlates with resolution and, in turn, sensitivity, as 
wavelength shifts in sharper peaks are easier to detect (within the limits of the 
detection device). 
 
Biosensing Applications.  Optical microring resonators have been used in proof-
of-concept studies to demonstrate detection of specific protein-protein 
interactions at the resonator surface.  Label-free detection of an avidin- or 
streptavidin-biotin interaction has been demonstrated on simple microring 
resonator structures using only silica or polymer as structural material (Chao et 
al., 2006; Yalcin et al., 2006; Ksendzov and Lin, 2005).  Immunobinding on more 
complex slot-waveguide structures was demonstrated with bovine serum albumin 
(BSA) with an anti-BSA antibody coupled to the sensing surface and label-free 
detection of antigen-antibody binding (Barrios et al., 2008).  The slot-waveguide 
resonator is similar to the simple resonator but is fabricated to include a vertical 
slot on the ring structure (Barrios et al., 2007).  Recently the utility of microring 
resonators for a wider range of biosensing applications has been shown 
(Ramachandran et al., 2008).  These studies demonstrated detection of DNA 
hybridization, quantitative antibody analysis and binding of whole E. coli O157:H7 
to the resonator surface.  Whole cell bacterial detection limits reported were on 
the order of 105 CFU/ml. 
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Figure 1.  Effect of ß-lactam antibiotics on penicillin binding proteins and 
cell wall synthesis.  Transpeptidase-mediated cell wall crosslinking continues in 
PBP2a (PBP2’) (green), while other penicillin binding proteins (red) are 
deactivated by binding of antibiotic to enzyme active site.  Figure from Hiramatsu, 
2001. 
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Figure 2.  Schematic diagram of different types of SCCmec.  mec: resistance 
to methicillin/oxacillin; ccr: site of cassette excision; pUB110: aminoglycoside 
resistance; Tn554: transposon encoding erythromycin and streptomycin 
resistance; ΨTn554: cadmium resistance.  Figure from Martins and Cunha, 2007. 
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Figure 3.  Examples of microcantilever devices.  Top:  An 8-cantilever array 
used for vapor sensing used as a deflection-type sensor.  Bottom:  A cantilever 
device with a single E. coli cell bound near the tip.  Bar equals 5 µm.  From 
Waggoner and Craighead, 2007.
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Figure 4.  Diagram of typical set-up for a surface plasmon resonance (SPR) 
biosensor.  Polarized light is directed through a prism to a layer of gold film to 
excite surface plasmons.  Reflected light is directed to an optical detection unit 
such as a diode array.  Bound mass on the sensor surface changes the angle of 
reflected light which is displayed on the sensorgram.  Figure from Cooper, 2003. 
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Figure 5.  Schematic of microring resonator.  (a) Arrows indicate the direction 
of light flow.  Resonant light from the input waveguide couples into the microring 
structure and circulates several times before a fraction escapes into the output 
waveguide.  (b) Cross-section of a vertically-coupled microring resonator. 
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CHAPTER III 
 
 
Use of Suppression Subtractive Hybridization to Identify Unique Markers 
for Clostridium piliforme isolate H1 
 
 
Introduction 
 
Tyzzer’s disease is a fatal, necrotic hepatitis caused by the obligate intracellular 
pathogen Clostridium piliforme.  The organism is capable of infecting multiple 
species and is most commonly observed in laboratory animals and horses.  
Bacteria within the species are identified by the host from which they were 
originally isolated during naturally occurring infections.  Previous reports have 
indicated there are differences in cytotoxic activity associated with different 
isolates when grown in vitro on different host cell monolayers, and that there is 
some heterogeneity in protein expression between isolates.  The isolate from 
hamster (H1) has been show to have higher cytotoxicity in vitro and is more 
capable of causing fatal infection in vivo across several species, and production 
of cytotoxic factors was suggested as a factor in increased pathogenicity.  The 
organism is difficult to maintain in culture, requiring host cells for intracellular 
propagation.  As a result, the organism is poorly characterized genetically, and
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 the only means of identifying presence of the organism by PCR is the use of 16S 
ribosomal markers as amplification targets. 
 
Suppression subtractive hybridization (SSH) was originally developed as a 
means of isolating unique coding sequences from eukaryotic organisms 
(Daitchenko et al., 1996), and has become a common procedure in differential 
eukaryotic expression assays (Kültz et al., 2007; Sternberg and Gepstein, 2007; 
Røsok and Sioud, 2007).  The procedure originally described involves ligation of 
different linkers containing internal PCR priming sites to 2 separate pools 
(“tester” pools) of total cDNA from the organism from which isolation of 
differentially expressed sequences is desired (Figure 1).  Hybridization to excess 
“driver” cDNA from a comparative sample is used to subtract fragments having 
high homology between the 2 tester pools and the driver sample.  Multiple 
hybridization steps coupled with downstream amplification results in a pool of 
cDNA which is present in the tester samples but not in the driver samples.  The 
procedure has been successfully applied to bacterial genomic studies to examine 
differences between genomic DNA pools (Huang et al., 2007; Winstanley, 2002), 
and has been developed into a commercial bacterial genomic analysis kit (PCR-
Select™ Bacterial Genome Subtraction Kit, Clontech). 
 
The goal of this study was to identify genomic sequences in C. piliforme cytotoxic 
isolate H1 which were not present in the non-toxic isolate R1 originating from a 
natural rat infection, and to associate these sequences with possible cytotoxin 
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production by the H1 isolate.  Results from this study could serve as a foundation 
for future work to isolate and clone genetic elements associated with cytotoxin 
production, and for isolation and characterization of H1-associated pathogenicity 
factors.     
 
 
Materials and Methods 
 
Culture of C. piliforme 
C. piliforme isolates R1 and H1 were a generous gift provided by Lela Riley 
(University of Missouri).  Bacterial isolates were cultured on buffalo rat liver cells 
(BRL 3A; ATCC CRL 1442) as previously described (Riley et al., 1990).  
Intracellular growth of bacteria in confluent host cell monolayers was monitored 
via inverted microscope, and when cultures were infected at high density, usually 
24-48 hr. post-inoculation, cells were scraped from cell culture flasks and frozen 
in culture medium containing 10% dimethyl sulfoxide in liquid nitrogen for later 
use.  Assay cultures were initiated by application of 1 ml thawed inoculum to BRL 
3A cells at ~70-80% confluence in multiple 75 cm2 tissue culture flasks.  Infected 
cell cultures were washed with fresh culture medium after 12 hours and grown 
until intracellular infection was well established. 
 
DNA Isolation 
C. piliforme DNA was isolated by scraping active cell cultures into a small volume 
of phosphate-buffered saline (PBS, pH 7.4) and host cells were lysed by 
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repetitive aspiration through a 1 ml micropipette tip.  Intact host cells and large 
debris were precipitated by centrifugation (300 x g, 20 min.).  Supernatant was 
collected and bacterial cells were recovered by high-speed centrifugation (10,000 
x g, 5 min.).  Excess host cell nucleic acids were removed by resuspending 
bacterial cells in PBS and repeating the centrifugation, with the wash procedure 
repeated 2 times.  Bacterial cells were lysed by incubation in SET buffer (25% 
wt/vol sucrose, 50mM Tris-HCl, 50mM EDTA) containing 1 mg/ml lysozyme 
(Sigma Chemical Co.) at 37C for 1 hr., followed by addition of sodium dodecyl 
sulfate (SDS) to a final concentration of 1% (wt/vol) and proteinase K (Promega) 
at final concentration of 1 mg/ml.  Samples were incubated at 55C for 2 hr. with 
occasional inversion, followed by addition of one-third volume sodium chloride 
and one volume chloroform.  Contaminants were removed by centrifugation 
(4500 x g, 15 min.).  Supernatant was recovered and further purified by phenol-
chloroform extraction and ethanol precipitation.  BRL 3A DNA was purified by 
standard phenol-chloroform isolation.  Bacterial and host cell DNA was analyzed 
by agarose gel electrophoresis to verify presence and purity of high molecular 
weight DNA following extraction 
 
Restriction Digestion of DNA 
In order to generate fragments of suitable length for SSH (<2000 bp) high 
molecular weight DNA was subjected to restriction digests with a mixture of 
frequently-cutting enzymes with 4 bp recognition sites.  Combinations of MspI, 
HaeIII, HinfI and Sau3A I enzymes (Promega) were used in an initial assay to 
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determine which combinations would result in desired fragmentation of DNA to 
be used in the SSH procedure.  Final restriction digestion utilized a combination 
of all enzymes as follows:  10 µg DNA, 12.5 µl universal reaction buffer and 12.5 
U of each enzyme in a total reaction volume of 125 µl at 37C for 13 hr.  Following 
digestion samples were blunt-ended by addition of 10 U T4 DNA polymerase, 
200 µM each of dATP, dCTP, dGTP and dTTP in a total reaction volume of 187.5 
µl with incubation at 37C for 1 hr., followed by addition of 12.5 U Klenow DNA 
polymerase and incubation at 37C for an additional hr.  Reaction products were 
purified by phenol-chloroform extraction and ethanol precipitation and 
resuspended in water at a final concentration of 300 ng/µl. 
 
Preparation of Tester (H1) DNA 
Preparation of H1 DNA to be used as tester followed the general procedure of 
Diatchenko et al. (1996).  Blunt-ended C. piliforme H1 tester DNA was diluted 1:5 
in distilled water and used in 2 separate adapter ligation reactions.  One reaction 
used 2 µl diluted tester (120 ng), 2 µl adapter 1 (10 µM), 0.5 U T4 DNA ligase, 1 
µl rATP, 1 µl ligase buffer and 6 µl distilled water.  The other reaction was 
identical with the exception of substitution of adapter 2 for adapter 1.  Samples 
were incubated at 16C for 16 hr., and then ligase was inactivated by addition of 1 
µl 0.2 M EDTA and heated at 70C for 5 min.  Sequences for adapters and PCR 
primers were as follows: 
Adapter 1: 
 
5’-GTAATACGACTCACTATAGGGCTCGAGCGGCCGCCCGGGCAGGT-3’ 
                                    3’-CCCGTCCA-5’ 
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Adapter 2: 
 
5’-TGTAGCGTGAAGACGACAGAAAGGGCGTGGTGCGGAGGGCGGT-3’ 
                                3’-GCCTCCCGCCA-5’ 
 
Primer 1:  5’-GTAATACGACTCACTATAGGGC-3’ 
 
Primer 2:  5’-TGTAGCGTGAAGACGACAGAA-3’ 
 
Primer N1:  5’-TCGAGCGGCCGCCCGGGCAGGT-3’ 
 
Primer N2:  5’-AGGGCGTGGTGCGGAGGGCGGT-3’ 
 
SSH Hybridization Procedure 
The hybridization procedure followed that of Diatchenko et al. (1996) with the 
exception that both C. piliforme R1 DNA and rat liver cell (bacterial culture host) 
DNA served as driver.  Thus, simultaneous subtraction of DNA fragments shared 
by both C. piliforme isolates and contaminating host cell DNA fragments was 
possible.  Two µl each of R1 and rat cell driver were added to 2 tubes containing 
2 µl of either adapter 1- or adapter 2-ligated H1 tester.  Samples were mixed and 
ethanol precipitated (15,000 x g, 20 min., 4C) and resuspended in 1.5 µl 
hybridization buffer (50 mM HEPES, pH 8.3/0.5 M NaCl/0.02 mM EDTA, pH 
8.0/10% (wt/vol) PEG 8000).  Individual tester samples were denatured at 98C 
for 1.5 min., and then held at 68C for 10 hr for the first hybridization step.  
Individual tester samples were then combined with the addition of 1.5 µl of heat-
denatured driver (1.5 µg each of R1 and rat DNA in hybridization buffer).  Pooled 
sample was hybridized an additional 10 hr at 68C, then diluted in 200 µl dilution 
buffer (20 mM HEPES, pH 8.3/50 mM NaCl/0.2 mM EDTA) and heated at 72C 
for 7 min. 
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PCR Amplification of Hybridization Products 
PCR amplification of hybridization products was performed as described by 
Diatchenko et al. (1996) with minor modifications.  An initial PCR reaction to 
amplify hybridization products was followed by a nested PCR reaction to further 
purify and amplify H1 unique sequences.  The first PCR reaction used 1 µl of 
diluted, subtracted DNA from the previous step, 1 µl each of 5 µM stock of 
primers P1 and P2, 1 µl dNTP stock (10 mM dATP, dCTP, dGTP and dTTP), 2.5 
µl AmpliTaq® PCR buffer (Applied Biosystems), 1 µl AmpliTaq® DNA polymerase, 
and 1µl MgCl2 (1.5 mM) in a 25 µl total reaction volume.  For both initial and 
nested reactions a parallel reaction using double the concentration of MgCl2 was 
performed to determine if elevated MgCl2 was beneficial to yield of final product.  
The nested reaction was the same as the initial reaction, with the exception of 
substitution of primers PN1 and PN2 for P1 and P2, respectively.  These nested 
primers anneal to binding sites incorporated into the adapter sequences ligated 
to H1 tester DNA immediately internal to the initial primer (P1 and P2) binding 
sites.  For the nested reaction 1 µl of a 10-fold dilution of the initial reaction 
product served as template.  All reactions used a common temperature cycling 
protocol:  75C for 7 min.; 30 cycles at (91C for 30 sec.; 68C for 30 sec.; 72C for 
2.5 min.); with a final extension at 68C for 7 min.  Following nested PCR a 
sample of each reaction product was subjected to agarose gel electrophoresis.  
Best product yield and product size diversity was obtained with elevated MgCl2 
level in the PCR reaction, and these products were used for all downstream 
cloning procedures. 
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Cloning and Analysis of PCR Products 
The TOPO-TA cloning system (Invitrogen) employing the PCR4-TOPO 
sequencing vector was used for cloning of PCR products.  Four µl of nested PCR 
product was used in the ligation reaction according to manufacturer protocols.  
Ligation product was transformed into TOP10 One Shot cells using 
manufacturer-recommended chemical transfection protocols.  Transformants 
were screened on Luria-Bertani agar plates containing IPTG and X-Gal for blue-
white colony selection.  White colonies representing clones with SSH product 
insert were picked and maintained for DNA sequencing.  Plasmid DNA was 
isolated from overnight cultures of insert-positive clones using the Wizard® 
Miniprep kit (Promega) according to manufacturer protocols.  Purified plasmid 
DNA was submitted to the Oklahoma State University Core Facility DNA 
sequencing service, with sequencing primers consisting of T7 sequencing primer.  
Resulting DNA sequences were used for computerized BLAST homology search 
(http://blast.ncbi.nlm.nih.gov) after trimming vector remnants from query 
sequences.  The “nr” database was used as were the default nBLAST algorithm 
settings. 
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Results and Discussion 
 
Subtractive Hybridization 
DNA cleavage by multiple restriction enzymes was quite efficient, with nearly all 
fragments below 1.5 kb.  Smaller fragment size was considered more desirable 
to maximize removal of rat host cell DNA by increasing overall hybridization 
efficiency.  A higher concentration of smaller fragments is expected to promote 
faster hybridization kinetics, particularly among highly complementary 
sequences, while smaller fragment size helps prevent loss of shorter unique 
tester sequences which may be embedded in longer sequences having overall 
comparatively higher complementarity to driver.  Post-hybridization nested PCR 
reactions run on agarose gels in parallel with original digested tester indicated a 
mixed PCR product size range similar to original digested H1 DNA (Figure 2). 
 
A total of 69 distinct colonies were picked from culture plates, cultured and 
plasmid DNA submitted for DNA sequencing.  Following BLAST analysis the 
majority yielded rat DNA sequences representing insert originating from rat liver 
cell DNA used as driver (19/69 colonies picked),  or mouse sequences, which are 
expected to be highly homologous to rat driver cell genomic sequences (9/69 
colonies picked).  These colonies were discarded, as were those having inserts 
matching human DNA sequences (12/69 clones).  Despite screening of colonies 
for plasmid insert using α-complementation culture conditions, 12 colony clones 
had no insert present by DNA sequencing analysis.  DNA sequences are 
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presented in the appendix alongside computer output of the BLAST search 
results.  
 
Generally, if sequences showed one or two medium- to low-strength matches (E 
value ~1 x 10-6 or greater) to human or mouse, and much lower homology to any 
other mammalian sequence, then the sequence was retained for further analysis.  
The E value or “expect value” is a parameter that describes the number of hits 
one can "expect" to see by chance.  The E value decreases exponentially as the 
total score of the match increases.  However, with shorter query sequences 
(such as many of the ones reported in the appendix) even a match over a 
relatively short stretch will give higher E values than may occur with a longer 
query sequence, since the query length is a component of the E value 
calculation.  For this analysis, if true matches to human, mouse or rat sequences 
occurred, it would be expected that similar matches in the genomic sequences of 
other species which are at least somewhat genetically similar, or possibly that 
multiple strong matches in the same sequence, would be seen.  In addition, there 
is always the possibility that some GenBank submissions are incorrect when 
added to the database, so indiscriminately discarding medium-strength matches 
could remove possibly useful sequences from the candidate list.  Using this 
strategy is more conservative, and potentially useful sequences are not 
discarded. 
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Cloned PCR product A1 is a good example (see appendix).  This sequence (122 
bp) had one medium-strength match to human ceramide kinase-like protein 
(E=1e-04), and much lower matches to everything else.  The remaining matches 
were mostly to plant sequences as well as some mammalian sequences, but the 
E value was sufficiently high to suggest this candidate should not be discarded 
and could possibly be used as template to generate primers to test for isolate H1-
specific PCR amplification.  In the case of shorter sequences, it is generally not 
feasible to design primers to amplify the entire fragment as a single amplicon 
because the likelihood of finding compatible primer pairs within such a short 
sequence is low.  Rather, in these cases the strategy is to synthesize a single 
primer to be used for sequencing of genomic DNA and, taking data from primer 
extension to generate PCR primer pairs from the extended sequence for testing 
H1 isolate-specific DNA amplification. 
 
PCR product A2 yielded matches to mouse sequences, but with very high E 
values (low match probability).  However, after 2 rounds of sequencing the query 
sequence still had over 10% unresolved bases and was not a suitable initiating 
sequence for primer walking exercises.  Remaining sequences, with the 
exception of K5 and K7, had complete or nearly complete sequence data with 
very few unidentified bases.   
 
Seven clones had a good match to bacterial sequences, of which 5 had 
Clostridium species within the top matches (A3, D2, E6, E1 and K4).  Two 
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products had extremely strong matches to Rhodobacter species, while 3 showed 
homology mainly to plant sequences.  While it is possible some similarity exists 
between Rhodobacter and C. piliforme, matches to plants may be representative 
of an artifact either introduced as a contaminant during sequencing or during the 
selection and cloning process. However, these sequences and corresponding 
database match data are presented in the appendix for the sake of completeness 
of data.  Remaining clones for the most part were cryptic with few acceptable 
matches reported, and may represent new, novel sequences and merit further 
investigation. 
 
Clone A3 was of particular interest because it had a significant match to a 
Clostridium species (Clostridium phytofermentans) and because it had sequence 
of sufficient length and composition to permit use as a target amplicon.  Primers 
were custom synthesized: 
Forward: 5’-AATCATAAATCTCTTGACTATATATCAACAAATG -3’ 
Reverse: 5’-GCGTCTGTAAACTTTCCATAGCTTT-3’ 
Genomic DNA from isolates H1 and R1 were subjected to PCR using the same 
parameters as described for nested PCR reactions.  Agarose gel electrophoresis 
indicated a band corresponding to the expected product size (106 bp) was 
present in both samples.  These results suggest clone A3 sequence may 
represent a C. piliforme-specific marker but is not specific for isolate H1. 
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Unfortunately, a failure of the cryogenic storage system resulted in loss of all C. 
piliforme stocks and additional testing using the remaining candidate clone 
sequences was not possible.  Nonetheless, the results obtained from clone A3 
analysis indicate isolation of a potentially useful marker for specific amplification 
of C. piliforme for use in diagnostic PCR assays.  Additional testing against 
closely related Clostridia and other species is indicated. 
 
 
Conclusions 
 
The results of the present study suggest the utility of suppression subtractive 
hybridization as a tool to identify unique genomic makers in an essentially 
uncharacterized obligate intracellular bacterial pathogen.  Although results of the 
experiment did not yield isolate-specific marker sequences, it did result in new 
sequences with the potential to serve as C. piliforme-specific markers, and as 
diagnostic tools to indicate the presence of Tyzzer’s disease.  Additional 
sequences were identified which may correspond to genomic sequences in 
isolate H1 which code for toxins or other pathogenicity factors, although these 
were not tested.  Future experiments can take advantage of these results by 
using sequences identified in this study as starting points for synthesis of 
sequencing primers to facilitate expansion of genomic sequence information by 
primer extension of H1 genomic DNA.  Expanded sequence information can then 
be used to identify and characterize coding sequence for possible cytotoxins or 
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other cytotoxic factors, and for assembly of target amplicons for H1- or C. 
piliforme-specific genetic PCR markers.  Here we have presented a method 
which allows identification of potentially useful markers in a largely 
uncharacterized intracellular pathogen even in the presence of contaminating 
host cell DNA.  The possibility of extending this methodology to other unknown 
organisms, particularly uncharacterized emerging pathogens, gives SSH high 
utility as a genomic analysis tool. 
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Figure 1.  Overview of suppression subtractive hybridization (SSH) 
procedure.  Fragmented genomic DNA from the sample from which one wishes 
to subtract, is split into 2 tester pools and different linkers are ligated to ends of 
fragments in each pool.  Two rounds of subtractive hybridization/PCR against a 
fraction having common elements to be subtracted (driver), results in isolation 
and amplification of sequences in tester populations which are not present in the 
driver population.  In the experiments described, H1 isolate DNA was tester and 
R1 isolate and rat genomic DNA served as driver.  Figure taken from the 
Clontech PCRSelectTM Bacterial Genome Subtraction kit User Manual (BD 
Biosciences Clontech). 
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Figure 2.  Results of nested PCR reactions of SSH product prior to cloning.  
A small size distribution is visible indicated by the smeared band.  Most product 
was in the range of 50-150 bp.  Lane identification: M, molecular weight marker; 
A, nested PCR from SSH procedure; B, restriction digested H1 genomic DNA 
used in SSH procedure.
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CHAPTER IV 
 
 
Development of an Amplified Fluorescent Antigen Displacement Assay For 
Detection of Methicillin-Resistant Staphylococcus aureus 
 
 
Introduction 
 
The goal of the described research was to develop a detection component for a 
highly sensitive, rapid, specific, and low-cost method for diagnosis of infections 
by methicillin-resistant Staphylococcus aureus.  The availability of a system 
capable of identifying antimicrobial-resistant bacteria will promote immediate and 
effective therapeutic intervention and will minimize the spread of antimicrobial 
resistance.  Such a sensor must be able to detect indicators of resistance.  For 
example, resistance indicators for methicillin-resistant S. aureus (MRSA) have 
been thoroughly researched and include the mecA gene and low-affinity penicillin 
binding protein 2a (PBP2a).  This work was undertaken to develop a sensor that 
will identify MRSA by detecting the PBP2a protein. 
 
Current assay strategies for detection of protein in clinical samples rely on 
antibody recognition of the protein target followed by some transduction event to 
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give a readable signal and detection of the presence of the protein and, in turn, 
detection of the organism from which it came.  Current microplate-based 
immunological assays can be very sensitive, particularly when coupled with 
fluorescent detection strategies.  However, these methods tend to be slow and 
labor-intensive and in many cases prone to error.  In the case of MRSA, the 
standard course of action when infection is a possibility, is confinement and 
treatment with potent antibiotics until a positive identification can be made after 
culturing the organism in the laboratory, often days later.  The aggressive 
antibiotic therapies include “last line of defense” drugs such as vancomycin.  
Unnecessary use of antibiotics is likely to hasten development of resistance to 
those drugs.  Therefore, it is highly desirable to have an assay that is rapid, 
sensitive and has the potential to be used at the bedside or within a physician’s 
office. 
 
Amplifying fluorescent polymers are a new generation of tunable poly(phenylene 
ethynylene)  (PPE) polymers that amplify the fluorescence response of each 
captured analyte molecule, thus attaining very high sensitivity (Figure 1).  These 
materials were developed by Professor Timothy Swager (MIT) (Swager, 1998; 
McQuade et al., 2000), and have been utilized in several sensor-based 
applications.  When the polymer is excited by light, photon energy in the form of 
excitons migrates rapidly along the conjugated polymer chain, and to some 
extent between chains.  Interaction with certain molecules (quenchers and 
fluorescence resonance energy transfer (FRET) acceptors) at any point along the 
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polymer chain can generate a collective response in the entire chain, visible as a 
decrease in fluorescence (“turn off” event) or increase in fluorescence, 
respectively.  In comparison to standard fluorescence interactions involving 
unimolecular fluorophore-quencher interactions, AFP-based systems have 
intrinsic amplifying capability by converting one quencher molecule interaction 
into multiple quenching events (Figure 2).  For biological agent detection, these 
PPE-based signal amplifying polymers have been modified and can be used in a 
number of different formats, including aqueous dispersions of nanoparticles, thin 
films (slide or capillary), membranes, fiber-optic probe constructs, and 96-well 
plates. 
 
The goal of the present study was to develop a rapid, sensitive assay to detect 
the protein which imparts the methicillin-resistant phenotype to MRSA.  The 
strategy was to couple the intrinsic fluorescent amplification potential of 
amplifying fluorescent polymer (AFP) with a simple immunological step involving 
displacement of a quencher-labeled peptide from an immobilized antibody, 
followed by flow of labeled peptide in vitro to an AFP-coated surface.  The 
presence of an amplified fluorescence quenching event would be the indicator for 
presence of the protein in the sample, and hence presence of MRSA. 
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Materials and Methods 
 
Determining Peptide Antigens 
Protein sequence representing PBP2a protein of S. aureus methicillin-resistant 
strain R27 was retrieved from PubMed protein database search (Accession 
X52593; http://www.ncbi.nlm.nih.gov).  In order to deduce expected surface-
exposed regions of the protein which could serve as appropriate antigenic 
targets, amino acid sequence comprising the catalytically-active transpeptidase 
domain was analyzed for local hydrophobicity, hydrophilicity, antigenicity and 
hydropathicity using VectorNTI software (Informax, Invitrogen Corp.).  Prediction 
of likely secondary structure used the NNPREDICT online analysis 
(http://alexander.compbio.ucsf.edu/~nomi/nnpredict.html).  Most probable 
surface-exposed epitopes were identified based on low hydrophobicity and high 
hydrophilicity, with bias toward regions with comparatively high antigenic index 
values.  Three regions were identified and custom 20 amino acid peptides were 
synthesized (ResGen, Invitrogen Corp.).  Sequences of the 3 peptides were as 
follows: 
Peptide 1:  N-term – TLDDKTSYKIDGKGWQKDKS – C-term (aa pos. 418-437); 
Peptide 2:  N-term – KDTKNKVWKKNIISKENINL – C-term (aa pos. 551-570); 
Peptide 2:  N-term – NVKDVQDKGMASYNAKISGK – C-term (aa pos. 632-651). 
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Antibody Production and Screening 
Monoclonal antibodies to PBP2a peptide antigens were produced by the 
Oklahoma State Hybridoma Research Center.  Custom peptides were 
conjugated via amine coupling to keyhole limpet hemocyanin carrier (Pierce) and 
pooled for mouse immunization.  Immune response was verified by screening 
against immobilized pooled peptide antigens, and cell fusions were performed 
using standardized protocols.  Supernatants from fusion cultures were tested for 
reactivity toward individual peptide antigens adsorbed to microplate wells with 
polyvalent anti-mouse IgG as secondary antibody using blank wells and bovine 
serum albumin (BSA)-adsorbed wells as controls.  Additional screening utilized 
peptide conjugated to BSA as carrier to allow efficient adsorption in microplates, 
as well as BSA alone as negative control.  Data from colorimetric Enzyme-linked 
Immunosorbent Assays (ELISAs) were subjected to one-way Analysis of 
Variance (ANOVA) to determine the three best candidate fusion lines for MAb 
production.  Purified monoclonal antibodies were tested by ELISA and western 
blot analysis, and class and isotype analysis.  Three antibodies were reactive to 
specific peptides as well as purified, soluble recombinant PBP2a protein: An IgM 
and two IgG2 antibodies.  Based on suitability for downstream applications the 
IgG antibodies were chosen for use in assay development.   Hybridoma clones 
expressing these antibodies were grown in batch culture and antibody was 
purified from culture supernatants using the MAbTrap Kit (Pharmacia) according 
to manufacturer protocols. 
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Recombinant Protein Construction, Expression and Purification 
Construction of water-soluble PBP2a protein followed the strategy of Wu et al. 
(1992) wherein the hydrophobic N-terminal 22 amino acids comprising a 
membrane-spanning region were deleted from the expression construct.  The 
complete PBP2a coding sequence beginning with tyr23 was generated by 3-step 
polymerase chain reaction amplification of genomic DNA from a methicillin-
resistant S. aureus reference strain (ATCC 43300) using custom primers: 
Forward: 5’-TATGCTTCAAAAGATAAAGAAAT-3’; 
Reverse:  5’-CATCGTTACGGATTGCTTC-3’.  
The reaction was performed using a proofreading polymerase for maximum 
fidelity (DeepVent®, New England Biolabs) and the reaction was as follows:  200 
µM each dNTP, 5 µl reaction buffer, 0.1 µg DNA, 1.5 U enzyme and MgSO4 to a 
final concentration of 7.5 mM.  Final reaction volume was 50 µl and the cycling 
profile was 94C/5 min.; 30 cycles of 52C/1 min., 72C/1 min., 94C/1 min.; 72C/5 
min.  The resulting product was purified by gel electrophoresis (QiaQuick Gel 
Extraction Kit, Qiagen) and incubated with dATP and Taq polymerase (1.5 µl 
AmpliTaq® buffer, 60 mM dATP, 1.5 mM MgCl2 and 1.25U AmpliTaq® 
polymerase (Applied Biosystems) at room temperature for 10 min.) to produce 3’ 
A-overhangs for ligation into the T7/NT-TOPO vector (Invitrogen).  This vector 
contains a T7 RNA polymerase binding site for high-level transcription, and 
expressed protein contains an N-terminal fusion domain consisting of an affinity 
tag, a 6X His region for metal ion chromatography (MIC) and an enterokinase 
cleavage site for release of the fusion component from solPBP2a protein.  The 
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PCR product was inserted in the expression vector using standard manufacturer 
protocols and chemically transformed into E. coli Top10 One Shot cells 
(Invitrogen) for screening by restriction analysis of plasmid DNA to determine 
proper insert orientation relative to vector, followed by DNA sequence analysis to 
verify correct protein coding sequence. 
 
The complete expression construct was purified (Wizard miniprep kit, Promega) 
and transformed into E. coli pLysS cells (Invitrogen) for protein expression.  
Cultures were induced with 1 mM IPTG to initiate expression of fusion protein via 
T7 RNA polymerase originating from host cells, cells were lysed by freeze-
fracture, and protein was purified according to manufacturer protocols using 
Talon® MIC resin (Clontech) and imidazole gradient elution per manufacturer 
specifications.  Purified fusion protein was subjected to SDS-polyacrylamide gel 
electrophoresis to verify presence of a single band representing the fusion 
protein product.  Excess imidazole was removed by exhaustive dialysis against 
PBS buffer. 
 
Peptide Displacement Assays 
Quencher-labeled peptide displacement assays were performed by competitive 
elution of labeled peptide from antibody using either unlabeled peptide or 
solPBP2a protein as displacing agent.  Monoclonal antibody was immobilized in 
protein-G activated microplate wells (Reacti-bind protein G plates, Pierce Bio) at 
a concentration of 10 µg/well following manufacturer protocols.  Quencher-
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labeled peptide was custom synthesized (SynPep Corp.) from P2 peptide 
sequence with a DABCYL label added during synthesis.  Microwells were 
washed twice with PBS buffer and labeled peptide was added at 100-fold molar 
excess to maximum expected bound antibody (according to manufacturer 
specifications) and incubated at 4C for 16 hr.  Microwells were washed 4 times 
with PBS buffer and unlabeled peptide or solPBP2a protein was added to wells 
to initiate antigen displacement.  Unlabeled peptide and protein concentration 
was varied among wells using 10-fold serial dilution ranging from 0.001 to 100 
pmol/well.  Following a 30 minute total incubation period at room temperature the 
contents of microplate wells were aspirated and applied to AFP-coated glass 
microcapillaries in a flow-through format within a bench top fluorometer 
(Fluoromax 2, Jobin-Yvon, Inc.).  AFP was diluted to a final concentration of 0.1 
mg/ml wt/vol in toluene and applied by addition of ~40 µl to the inside of a pre-
etched capillary with a syringe and 27g needle, followed by spinning of the 
capillary in a spin-coating device at ~3000 x g for 20 seconds to remove excess 
AFP solution.  Prior to addition of displacement samples capillaries were washed 
with 500 µl PBS buffer (approximately 50 times internal capillary volume) at a 
flow rate of approximately 0.25 ml/min. to allow buffer-polymer equilibration, to 
elute unbound polymer and to facilitate baseline fluorescence values.  High 
between-capillary variability precluded the use of individual capillaries for each 
displacement assay sample.  Instead, samples were applied in succession from 
lowest to highest concentration of displacing agent within a single capillary.  An 
additional correction factor was applied by running parallel assays using bare 
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glass capillaries to determine fluorescence associated with assay samples.  
These values were then subtracted from corresponding sample-AFP values to 
yield the fluorescence value corrected for intrinsic sample fluorescence. 
 
 
Results and Discussion 
 
Peptide Antigen Selection 
The results of in silico selection of potential antigenic peptide antigens are 
summarized in Figure 3.  The selection strategy relied upon selecting peptide 
sequences in regions with highest likelihood of surface exposure on the intact 
and correctly folded native protein.  Regions with low hydrophobicity and high 
hydrophilicity are most likely to be exposed on the surface, while the reverse 
characteristics are more suitable for peptides buried within the hydrophobic 
interior of the intact protein.  Three peptides were selected primarily on 
hydrophobicity/hydrophilicity characteristics, and to a lesser extent hydropathicity 
and antigenic value indices.  Results of NNPredict analysis (Figure 4) were 
compared to predicted peptide hydrophobicity plots and regions lacking 
secondary structure with low hydrophobic potential were selected.  During the 
course of this study the 3-dimensional structure of native PBP2a protein was 
determined by NMR (Lim and Strynadka, 2002).  The location of selected peptide 
regions, and that of peptide 2 in particular are shown in Figure 5.  The results 
indicate excellent prediction of surface-exposed regions for antigenic peptide 
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synthesis.  The region indicated for peptide 2 is well-exposed and is expected to 
interact efficiently with antibody in competitive binding assays. 
 
Antibody Screening 
Screening of 78 monoclonal antibody fusion stocks yielded 3 candidate 
antibodies which were reactive to peptide antigens in ELISA assays using 
peptide adsorbed directly to microplate wells or conjugated to BSA prior to 
adsorption.  Western blot analysis was performed against solPBP2a protein and 
all antibodies were shown to bind recombinant protein.  Further characterization 
and isotyping of candidate antibodies indicated one antibody was IgM, while the 
remaining 2 were IgG2.  In the interest of downstream assay development the 
IgM candidate was rejected.  The remaining candidates were both identified as 
reactive and specific to the same immunizing peptide antigen, peptide 2.   
 
Antigen Displacement 
Recombinant soluble PBP2a protein was prepared in milligram quantities from 
large-scale culture.  Results of immobilized metal ion chromatography using 
imidazole gradient were unsatisfactory and resulted in several bands ranging in 
size from 8 to ~75 kDa.  It was necessary to modify protein purification to include 
2 steps, an initial imidazole gradient followed by a second round of IMAC 
purification employing a 50 mM imidazole wash step to remove contaminants 
prior to final elution of solPBP2a with 100 mM imidazole.  Although total protein 
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yield was greatly reduced, this method did result in a single protein product 
(Figure 6). 
 
Initial displacement assay experiments utilized a custom capillary tube holder 
fitted to a bench top fluorometer, with a new AFP-coated glass capillary tube 
used for each antigen displacement sample.  However, fluorescent intensity was 
highly variable both between capillaries and even within individual capillary tubes 
as a result of orientation-dependent light scattering due to variations in capillary 
geometry.  Final assay measurements employed a modified capillary holder to 
facilitate flow-through, stop-flow assays (Figure 7).  The capillary holder was 
fitted to the bench top fluorometer and AFP was interrogated at peak excitation 
(405 nm) and emission (460 nm) wavelengths.  Data was collected via software 
provided by instrument manufacturer (Jobin-Yvon, Inc.).  Following equilibration, 
samples were applied to the capillary column via syringe, small-bore tubing and a 
27 ga. needle piercing a septum holding the capillary in place.  In this manner it 
was possible to apply samples without disturbing the capillary tube and in turn 
introduce uncontrolled variation in fluorescent intensity from the glass capillary.  
Baseline polymer response to DABCYL-labeled and unlabeled peptide and 
solPBP2a protein was determined by application of successively higher 
concentrations of these analytes to an AFP capillary and determining fluorescent 
intensity after each addition. In this manner it was possible to evaluate the effect 
of each of these sample types on AFP fluorescent response.  The flow-through 
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design allowed incoming sample to efficiently and completely replace resident 
sample in the capillary. 
 
In order to assess the reactivity of the system to pure analyte and to begin to 
evaluate the sensitivity of a capillary-based AFP detection system the effect of 
increasing amounts of DABCYL-labeled peptide added to AFP was evaluated 
(Figure 8).  Addition of labeled peptide had little fluorescence quenching effect 
until the 1 pmol sample suggesting general assay sensitivity in the 0.1-1 pmol 
range.  There was a concentration-dependent quenching effect out to 1 nmol 
labeled peptide addition, which resulted in nearly a 50% reduction in 
fluorescence of polymer.  A nonlinear effect was noted in the 0.1 to 10 pmol 
range, which is in agreement with the amplifying characteristics of the polymer.  
Small concentrations of quencher are expected to have a large effect on polymer 
fluorescence due to quenching of entire fluorescent polymer chains.  It is 
important to note that polymer coatings within capillaries represent layers of 
individual polymer strands, and the most rapid quenching effect is expected to 
occur on the surface of the polymer, with quenching of deeper layers dependent 
upon diffusion of quencher into the polymer layers.  Although some interstrand 
quenching (i.e., between layers) is possible, the most efficient quenching effect 
involves the interaction of quencher with individual conjugated polymer chains.  
At higher concentrations of quencher there is expected to be a concentration-
driven shift in diffusion characteristics to enable interaction with deeper polymer 
layers.  This effect is becomes apparent beyond the 10 pmol labeled peptide 
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sample, resulting in a more extensive quenching effect.  The initial increase in 
fluorescence at lowest sample concentration is of minimal concern and may be 
representative of the inherent noise in the assay. 
 
An important consideration in the assay is the contribution of the peptide 
component to the overall quenching effect.  In order to evaluate the effect of 
peptide on AFP fluorescence, increasing concentrations of unlabeled peptide 
were applied to AFP capillaries (Figure 9).  The result was a general linear trend 
representing a concentration-dependent decrease in fluorescence with 
increasing peptide concentration, indicating some contribution of peptide 
component  to polymer quenching.  However, the result was difficult to quantify 
due to increased fluorescence associated with the 100 pmol sample in 
comparison to the 10 pmol sample.  Regardless, comparison of lowest-
fluorescence sample with starting fluorescence indicated approximately 2.5% 
quench could be attributable to quenching of polymer by peptide component.  
These results suggest a better test of assay sensitivity and range could be 
obtained by applying only the DABCYL quencher to AFP, rather than labeled 
peptide as described above.  However, the interaction of simple quencher with 
polymer surface is expected to be dissimilar to labeled peptide due to smaller 
molecular size, which would alter diffusion characteristics into multiple polymer 
layers.  In addition the AFP has a highly hydrophobic nature which, when 
combined with native hydrophobicity of the DABCYL structure, would introduce 
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confounding quencher-polymer affinity effects due to hydrophobic interaction at 
the polymer surface. 
 
The effect of increasing solPBP2a protein on AFP fluorescence was more 
substantial (Figure 10).  As with the peptide samples, a concentration-dependent 
decrease in AFP fluorescence was observed with increasing protein 
concentration.  The trend appears more linear in comparison to peptide, and 
maximal quench at highest protein level tested (100 pmol) was 13.6%.  In the 
intended assay, antibody is bound to a solid surface, possibly within a small 
chamber or flow cell, and incoming PBP2a protein from a clinical sample 
competes with bound peptide for antibody binding sites.  In this scenario the 
incoming protein becomes bound while liberating labeled peptide, and the free 
(liquid) sample is transferred to the transduction cell containing AFP.  Thus, the 
impact of the concentration-dependent quenching effect of target protein is 
diminished somewhat.  Of greater concern is the overall purity of the sample and 
the effect of a potentially higher concentration of contaminating proteins in the 
sample.  However, the availability of the native protein target to participate in the 
assay is restricted due to its location between the bacterial cell wall and the 
cytoplasmic membrane.  It is anticipated that some level of purification is 
necessary in the final assay format to liberate the native protein and make it 
available for detection.  If the quench associated with increased protein is indeed 
directly protein-associated, this scenario could pose significant problems to 
assay development, as even a purified sample would likely have a large 
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concentration of contaminating proteins.  It is possible that this effect could be 
diminished by using diluted samples to decrease the effect of total protein on 
AFP fluorescence, but this would be at the risk of assay sensitivity. 
 
Parallel antigen displacement assays were performed on both candidate IgG 
antibodies immobilized in protein-G derivatized microplate wells using both 
unlabeled peptide and recombinant solPBP2a protein as the displacing agent.  
Displacement assay results for one of the antibodies was highly variable with 
poor response, particularly with unlabeled peptide as displacing agent.  These 
results suggest this antibody candidate had low affinity for labeled peptide 
antigen and was deemed unsuitable for continued analysis or assay 
development.  The remaining antibody displayed better performance, and AFP 
quenching plots for protein and unlabeled peptide as displacing agent is shown in 
Figure 11.  In both cases there is a concentration-dependent quench of the 
polymer, with the displacement product associated with protein detection 
approximately 3-fold greater compared to peptide at higher assay concentrations. 
 
Additional testing of monoclonal antibodies against crude lysates from MRSA 
and MSSA reference strains was performed.  Western blot analysis indicated 
reactivity of both antibodies to a >70 kDa protein in the MRSA strain (expected to 
be PBP2a), but a much stronger band was observed at ~54 kDa in both strains 
(data not shown).  The identity of the smaller band is unknown, but strong 
reactivity between both MRSA and MSSA renders the antibodies produced 
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during this study ineffective at distinguishing between methicillin-resistant and 
sensitive strains using a displacement component similar to the one described.  It 
is possible there is cross-reactivity with another PBP, possibly the lower 
molecular weight PBP4 protein, but it was not possible to determine if that was 
the case as the protein associated with this band was not identified or 
characterized.  Saito et al. (1995) reported development of an anti-PBP2a 
antibody using synthetic peptides as immunizing antigen.  The monoclonal 
antibodies produced during this study were raised against 20-mer peptides 
similar to those reported by that group, and one peptide sequence overlapped 
the peptide sequence of one of peptides used successfully in that study.  A key 
difference may lie in the presentation of antigen during the mouse immunization 
procedure.  In this study the peptides were directly conjugated to hemocyanin via 
an EDAC linker, whereas they used linkage through an N-terminal cysteine 
residue and a bifunctional linker to attach it to a BSA carrier.  The direct 
attachment used in this study may have restricted epitope accessibility or 
physically forced the peptide into a conformation which was non-native, leading 
to production of antibodies that recognized an incorrect peptide conformation. 
 
However, the displacement assay utilized targets which had been previously 
shown to react with the antibodies, either during the antibody selection process 
as with peptide, or by western blot analysis with the recombinant solPBP2a 
protein.  Therefore, the results presented for the displacement assay should be 
interpreted as a proof-of-concept study to demonstrate the utility of AFP to detect 
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labeled peptide displaced by incoming antigen.  In this context the system 
appeared to function as intended. 
 
Successful incorporation of a displacement component similar to the one 
described (utilizing more appropriate antibodies) into a device for a medical 
application presents additional challenges.  The effect of protein on AFP function 
must be considered, as clinical samples are expected to contain copious 
amounts of non-PBP2a protein.  A significant quench of AFP was apparent when 
increasing concentration of unlabeled protein was added to the displacement 
reaction, and future development of an AFP signal transduction system must be 
able to discriminate true quench associated with PBP2a from that associated 
with general protein effect.  One possible solution is isolation of S. aureus from 
the clinical sample prior to lysing and presenting to the assay platform.  This 
could be accomplished by immunomagnetic separation using antibodies against 
Staphylococcus, while actual discrimination between MRSA and MSSA could 
occur in the displacement assay.  However, addition of purification steps will 
undoubtedly complicate the assay and increase assay time and may not be 
feasible for final assay development. 
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Conclusions 
 
The results of this study demonstrate the potential utility of labeled peptide 
displacement assays when performed in conjunction with AFP.  Proof-of-concept 
experiments demonstrated displacement and detection of a labeled peptide via 
fluorescence quenching of AFP.  Some limitations may exist in direct 
incorporation of an assay of this type into a biomedical detection platform due to 
the effects of extraneous protein on AFP fluorescence.  Additional investigation 
regarding protein-AFP interaction is needed to determine true feasibility of the 
assay described in this study.  Future experiments should include additional 
testing of AFP with increasing concentrations of contaminating protein.  Further 
development of PBP2a-specific antibodies is also needed.  In addition, 
incorporation into a final flow-based diagnostic antigen displacement assay will 
require extensive testing of reaction conditions (flow, buffer composition, etc.) 
and optimization of antigen-antibody affinity to give best sensitivity with lowest 
possibility of false-positive results. 
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Figure 1.  Features of amplifying fluorescent polymer (AFP).  Space-filling 
model (left) and general chemical structure (right).  The AFP backbone is 
responsible for the intrinsic amplification of AFPs, while the rigid pentiptycene 
scaffold prevents quenching of the AFP’s fluorescence.  The pendant side chain 
substituents are critical for solubility of the AFP and provide a synthetically 
versatile point to directly modify the AFP, affecting the surface chemistry of AFP 
films. 
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Figure 2.  Comparison of traditional chemosensors to molecularly wired 
sensors. 
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Traditional chemosensor (isolated chromophores):  Binding of an analyte molecule
quenches only the chromophore to which it binds.
Receptors wired in series  (molecular wire arrangement):  A single molecular binding
event quenches the fluorescence of many chromophores, amplifying the chemosensory
response by orders of magnitude.
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Figure 3:  Antigenic peptide prediction based on computer analysis of 
transpeptidase domain of PBP2a from Staphylococcus aureus.  Green 
boxes denote regions containing peptide sequences used in this study. 
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Figure 4:  Results of NNPredict secondary structure prediction for PBP2a 
protein.  Regions less likely to participate in secondary structure (dashed lines) 
were targeted as possibly surface-exposed, and hence better antigenic 
sequences. 
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Results of nnpredict query 
Tertiary structure class: none  
 
Sequence saBAA86650: 
mkkikivplilivvvvgfgiyfyaskdkeinntidaiedknfkqvykdssyisksdngev 
emterpikiynslgvkdiniqdrkikkvsknkkrvdaqykiktnygnidrnvqfnfvked 
gmwkldwdhsviipgmqkdqsihienlksergkildrnnvelantgtayeigivpknvsk 
kdykaiakelsisedyikqqmdqnwvqddtfvplktvkkmdeylsdfakkfhlttnetes 
rnyplekatshllgyvgpinseelkqkeykgykddavigkkgleklydkklqhedgyrvt 
ivddnsntiahtliekkkkdgkdiqltidakvqksiynnmkndygsgtaihpqtgellal 
vstpsydvypfmygmsneeynkltedkkepllnkfqittspgstqkiltamiglnnktld 
dktsykidgkgwqkdkswggynvtryevvngnidlkqaiessdniffarvalelgskkfe 
kgmkklgvgedipsdypfynaqisnknldneilladsgygqgeilinpvqilsiysalen 
ngninaphllkdtknkvwkkniiskeninlltdgmqqvvnkthkediyrsyanligksgt 
aelkmkqgetgrqigwfisydkdnpnmmmainvkdvqdkgmasynakisgkvydelyeng 
nkkydide 
 
 
Secondary structure prediction (H = helix, E = strand, - = no 
prediction): 
-----E-EEEEEEEEE--EEEEE----------H--HHH----HE-----EE-------- 
-H----HEEE---------HHHHHHHHHH--------HEEE----------H-------- 
---E-------E---------EEEE--------E----H-HHH-----EEEEE------- 
-HHHHHHHHH---H-HH----------------------HHHHHHHHHHHH--------- 
-------HHHHHE---------HH-HHH-------HHHH---HHHHHHH--------EEE 
EE------HHHHHHHH-------HEEEHHHHH---HH-----------EE-----HHEEE 
----------EE------------------------EE-------EEHEHHHH------- 
-----EE-----------------EEEE------HHEH------HHEHHHHHHHH-HHHH 
HHHHH------------------------HHHHE--------EEEE---EEEEEEHH--- 
----------H-----------------HHHH--HHHHH-------HHHHHHHEE----- 
HHHHH-------EEEEEEE--------HHEE------------E--------E-HHHH-- 
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Figure 5.  Three-dimensional structure of PBP2a.  (a.) Location of synthesized 
peptide sequences within the protein structure, (b.) Location, orientation and 
sequence of antigenic peptide 2. 
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Figure 6.  Results of imidazole pre-wash on purity of solPBP2a protein. (l) 
Highest purity protein possible with single-step IMAC gradient elution assay, (r) 
High purity sample following imidazole pre-wash step.  M: molecular weight 
marker; Lanes 1-5: elution with increasing imidazole concentration.
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Figure 7.  Capillary tube holder used in these assays.  AFP-coated glass 
capillary tube is fitted to holder and samples from displacement reactions flow 
vertically from tube to bottom through the flow apparatus. 
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Figure 8.  Effect of increasing DABCYL-labeled peptide on AFP 
fluorescence in the capillary flow system.  In this case there was no 
displacement reaction.  Labeled peptide was added from stock to help estimate 
sensitivity of the AFP capillary assay.
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Figure 9.  Effect of increasing concentration of unlabeled probe on AFP 
capillary fluorescence.
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Figure 10.  Effect of increasing concentration of unlabeled solPBP2A 
protein on AFP capillary fluorescence. 
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Figure 11.  Results of peptide displacement reaction using unlabeled probe 
or solPBP2a protein as displacing agent.  DABCYL-labeled peptide was 
preloaded onto immobilized antibody and was displaced by peptide or protein for 
interaction with AFP. 
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CHAPTER V 
 
 
Multiplex Microring Resonator-Based Assay for Detection of Salmonella 
Typhimurium and Escherichia coli O157:H7 
 
 
Introduction 
 
Rapid and simple detection of foodborne pathogens is currently of great interest, 
both from the standpoint of food production and for rapid diagnosis of clinical 
disease associated with these organisms.  The negative effects of E. coli 
O157:H7 and Salmonella on human health and food production are immense, 
and they can have serious economic impact.  Current methods of detection tend 
to be laborious and time-consuming, and in some cases a compromise between 
speed and sensitivity is necessary.  New biosensor technologies have the 
potential to greatly enhance detection capabilities without compromising time to 
results.  Label-free assays are of great interest and a number of platforms are 
currently in development. 
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In recent years, different sensor platforms exhibiting enhanced detection 
capabilities, based on potentiometric, amperometric, magnetic, and optical 
transducers have been developed (Lazcka et al., 2007).  One of these promising 
new technologies involves the use of microring resonators as optical sensors for 
detection of biomolecules.  Operating as bound mass signal transducers, these 
devices have the flexibility to be used for a range of biodetection applications.  
Microring resonators offer several advantages for use as biosensing platforms. 
They provide label-free, sensitive, and real-time detection capabilities. The small 
form factor facilitates production of arrays of individually-addressable sensing 
elements on a single chip using standard photolithographic fabrication methods, 
enabling multiplexing capabilities. In addition, microring resonator chips can be 
mass produced at low cost, enabling incorporation into disposable 
detection/diagnostic devices.  This report details the use of microring resonators 
as a label-free platform for detection of the major foodborne pathogens E. coli 
O157:H7 and Salmonella Typhimurium, and demonstrates the utility of the 
platform as a multiplex assay system.  
 
 
Materials and Methods 
 
Microring Resonator Chips 
Microring resonator sensing chips were obtained from the Little Optics division of 
ICx Technologies.  Chips were created from silicon wafers using optical 
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photolithography and employed proprietary silicon (glass)-based material called 
Hydex™ (Yalcin et al., 2006; Hryniewicz et al., 2004).  The glass-based Hydex™ 
material is a low-loss, high-refractive index substrate ideally suited to fabrication 
of MR devices due to exceptionally low bending losses, enabling fabrication of 
devices with very tight radii (small diameter).  The high-density wafer-based 
fabrication process results in a large number of chips (>100) diced from a single 
wafer with high chip-to-chip uniformity in physical specification and optical 
characteristics.  Chips used in this study contained 5 independently-addressable 
microring structures with a 100 µm diameter and cross-sectional dimensions of 
0.75 µm wide by 1.5 µm high.  Each ring was optically coupled to individual input 
and output waveguide buses buried within the chip structure, such that vertical 
optical coupling of waveguide buses and sensing microring structures was 
achieved (Figure 1) (Yalcin et al., 2006).  Optical fiber cables were used to 
connect sensing chips with the optical interrogation system.  One end of the 
cable was fitted with a precision-aligned terminator which was butt-coupled to the 
sensing chip, while the other end was terminated in optical MTP-style 
connectors. 
  
Reader System and Determination of Resonance Wavelength 
In order to determine the initial resonance wavelengths of individual micro-rings 
on the micro-ring resonator chip, and to monitor shifts in the resonance 
wavelengths over time, a reader system consisting of an optical spectrum 
analyzer (OSA, ANDO-AQ6317B), a broadband light source (1.53–1.61 µm, 
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Thorlabs Inc., ASE-FL7002) and an optical switch (JDS Uniphase) were used.  
The input and output waveguides of the micro-ring resonator chip were 
connected to the broadband light source and the OSA, respectively, via the MTP-
terminated optical fiber tail of the microring resonator chip. Detecting shifts in 
resonance peaks was accomplished using OSA-based scanning of the output 
waveguide wavelengths, with data collected in real-time and displayed on a 
desktop computer using a dedicated software package created by Little Optics.  
The optical switch facilitated repeated sequential channeling of light to the five 
rings.  The scan rate for the system was approximately 15 seconds per microring 
channel. 
 
Microring Resonator Chip Functionalization 
Antibodies were coupled to the microring surface via covalent attachment of 
surface-exposed antibody amine groups to epoxy-modified sensing surfaces.  
When new chips were used they were first cleaned by immersion in 1% sodium 
hydroxide in a 60% ethanol/40% water solution for 30 minutes.  Preparing chips 
which had been used previously was similar, with the exception of a preliminary 
etching in 100 mM aqueous sodium hydroxide solution for 30 minutes at room 
temperature to remove any contaminating material.  Chips were thoroughly 
rinsed in deionized water followed by 95% ethanol.  Epoxysilane groups were 
generated on the chip surface by immersing cleaned chips in a solution 
containing 10% GPTS (3-glycidoxylpropyltrimethoxysilane) and 10mM acetic acid 
in 95% ethanol for 30 minutes.  Following silanization, the chips were rinsed 
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thoroughly with 95% ethanol.  Epoxysilane-modified surfaces were cured by 
baking in an oven at 120ºC for 1 hour. Chips were stored in a desiccator until 
antibody attachment. 
 
E. coli Whole-Cell Binding Experiments 
Initial experiments were directed toward detection of whole bacterial cells in broth 
suspensions to demonstrate feasibility of microring-based bacterial detection.  
Paired microrings on a chip (rings 1 and 2 or rings 4 and 5) were functionalized 
with monoclonal antibody specific for LPS oligosaccharide of E. coli O157:H7 
(Abcam Inc., Cambridge, MA, USA) or with a negative control antibody 
previously shown to be nonreactive to E. coli.  Antibodies were suspended in 
phosphate-buffered saline (PBS), pH 7, to a concentration of 1 µg/µl and mixed 
with 10mM sodium hydroxide in 5:1 ratio to give an antibody solution with a final 
pH of 10. Antibody solution (~0.5 µl) was applied over each of the micro-rings 
and allowed to bind overnight at 4ºC in a humidified chamber. 
 
Following antibody binding, microring resonator chips were subjected to a 
blocking and washing cycle in order to neutralize unreacted epoxysilane groups 
on the chip surface and to remove any excess unbound fraction of antibodies.  
Chips were washed in PBS buffer (pH 7) then the chip surface was blocked with 
1% bovine serum albumin (BSA) in PBS for 30–45 min and rinsed with PBS–
Tween solution (PBS, pH 7 with 0.5% Tween-20) followed by two rinses with 
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PBS alone. Each rinse procedure was performed for 10 minutes.  In this manner, 
the untreated ring to be used as reference (ring 3) was blocked with BSA.   
 
The MR chips were connected to the reader system via the optical fiber tail using 
standard MTP connectors. Chips were immersed in a 2 ml cryovial tube 
containing 2ml PBS to determine initial resonance wavelengths and to establish 
a baseline.  E. coli O157:H7 cells in broth culture (~2x109 cells/ml) were spiked 
into the buffer at a final ratio of 1:1 culture:buffer to yield a final concentration of 
109 cells/ml.  Solutions were continuously stirred using a magnetic micro-stir bar 
while monitoring resonance wavelength shift over time to detect target-binding 
events.  As with other RI sensing methods, where RI is a function of temperature, 
the microring resonator signal is also temperature-sensitive.  To minimize 
temperature-induced signal drift, all experiments were performed at room 
temperature, with samples and buffers pre-incubated at room temperature prior 
to detection.  In addition, the temperature-induced drifts were minimized by 
subtracting the reference ring signal (BSA blocked, no antibody) from the 
antibody-activated sensing ring signal.  A parallel assay was performed on 
identically-treated but non-connecterized chips (no optical fiber cable), and these 
chips were used for scanning electron microscopy (SEM) analysis to confirm 
bacterial binding to relevant microrings. 
 
 109 
Multiplexed Whole Bacterial Cell Detection Assays 
The ability to function in multiplexed whole cell assays was determined by 
functionalization of MR chips with monoclonal antibody directed toward E. coli or 
Salmonella Typhimurium LPS, followed by sequential whole cell binding assays.  
Although not a multiplexed assay per se, as the detection process does not 
involve simultaneous detection of different targets, the term multiplex is used in 
the context of this report to indicate capability to be incorporated into a multiplex 
assay following demonstration of specificity to multiple targets in sequential 
binding assays.  Initial assays used high concentrations of target cells in buffer in 
a stirred-tube assay format.  Further experiments were performed with lower cell 
concentration either applied directly to the microring sensing surface or in 
conjunction with a dedicated custom microflow cell apparatus. 
 
High Concentration Multiplex Assay 
Monoclonal antibody to E. coli O157:H7 (described above) and S. typhimurium 
LPS (0-4 serotype specific; Abcam Inc., Cambridge, MA, USA) was diluted to a 
final concentration of 0.1 mg/ml in PBS buffer (pH 10) and spotted (>0.5 µl) onto 
epoxysilane-activated rings (described above).  Pairs consisting of adjacent rings 
(rings 1 and 2, or rings 4 and 5) were spotted with like antibody, while the center 
reference ring was spotted with 1 mg/ml BSA in PBS (pH 10).  Covalent coupling 
of antibody or BSA to microring surface was accomplished by overnight 
incubation at 4ºC in a humidified chamber.  Following overnight incubation, chips 
were washed with PBS (pH 7) with gentle agitation.  Because high antibody 
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concentration was used in conjunction with direct covalent coupling of BSA to the 
reference ring, additional BSA blocking steps, as described for initial whole cell 
detection assays, were omitted. 
 
Antibody-derivatized chips were placed in 2 ml PBS buffer (pH 7) in a stirred 
cryovial tube for initial resonance peak detection and to establish a 30-minute 
buffer baseline.  Half of the buffer was removed and replaced with bacterial 
suspension culture as described above, to yield a final cell concentration of 
approximately 109 CFU/ml.  Resonance shift was continuously monitored for 45 
minutes.  Following first bacterial binding, recording was halted momentarily to 
aspirate away the bacterial test suspension and replaced with PBS.  This 
procedure was repeated twice more to remove as much of the first bacterial 
suspension as possible.  Two ml of PBS was then added to the tube and 
resonance wavelength monitoring was resumed.  After approximately 1 hr. the 
second (alternate) bacterial test suspension was added in the same manner as 
the first suspension to achieve ~109 CFU/ml cell density.  Wavelength monitoring 
continued for 45 minutes, followed by washing and re-equilibration in fresh PBS 
buffer.  Results of wavelength scans were averaged across antibodies 
(measurements from rings with like antibodies) and were corrected for 
temperature by subtraction of reference ring scan values. 
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Low Concentration, Direct Application Multiplex Assay 
In an effort to enhance response time during whole cell multiplex assays, lower 
concentrations of bacterial test suspensions were applied directly to the MR 
sensing chip.  Preparation of chips was as described above for the high 
concentration assay, as was the initial baseline measurement, except baseline 
collection time was extended to 1 hr.  Presentation of the first whole cell bacterial 
suspension was accomplished by halting scanning, removing excess buffer from 
the chip and placing the chip in a horizontal position in a high-humidity chamber.  
Twenty microliters of bacterial cell suspension at a concentration of 1x105 
CFU/ml (2000 cells total) was pipetted directly on to the surface of the MR chip, 
completely covering the sensing rings.  Wavelength scanning resumed for 
approximately 25 minutes, then halted to remove bacterial suspension and to 
transfer the chip back to the stirred cryovial.  Wavelength scanning resumed for 2 
hrs. to ensure stable baseline and to remove all unbound cells.  Scanning was 
again halted to allow presentation of the second (alternate) bacterial suspension 
in the same manner as the first.  Scanning resumed and after approximately 30 
minutes the chip was re-equilibrated in PBS buffer in the manner following the 
first sample presentation.  Measurement averaging and reference subtraction 
were as described for high concentration multiplex assays. 
 
Low Concentration Flow Cell Multiplex Assays 
In order to further enhance mass transport of analyte (bacterial cells) to the 
sensing surface, a custom flow cell was fabricated to hold a microring resonator 
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chip (Figure 2).  The format for the cell is input and output microchannels 
connected to a small chamber volume defined by a channel cut from gasket 
material.  The gasket channel is fabricated such that when the MR chip is 
mounted all active rings are within the channel volume.  Initial attempts utilized 
an acetate film as the gasket material, which was then replaced by skived 
Teflon™ sheeting.  The flow channel was cut manually under magnification using 
a template, and the dimensions of the channel were 5.5 mm long by 
approximately 1.2-1.4 mm wide by 100 µm high (the thickness of the skived 
Teflon™), for a total volume of approximately 650-750 nl.  Sensing chips were 
prepared as previously described for multiplex assays and mounted in flow cell 
apparatus.  Flow rate and volume of cell suspension were controlled by syringe 
pump, and small-bore Teflon™ tubing connected a disposable plastic syringe to 
the flow cell.  The flow cell cover containing the input and waste pathways was 
machined from polyetheretherketone (PEEK), while the base was aluminum for 
efficient heat conductivity to the MR chip. 
 
Multiplex MR chips were prepared as described above and mounted into the flow 
cell by sandwiching between the cover and base, with the gasket material 
between the chip surface and the flow channel cover.  Maximum flow rate was 
set at 0.1 ml/min. with a total volume of 1 ml.  During the assay, sample was 
infused with constant wavelength scanning, followed by static-phase incubation 
for a total time ranging from 25-45 min. at each step.  Bacterial suspensions of 
104 or 105 cells/ml were prepared in PBS (pH 7) by dilution from bacterial culture.  
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Wavelength scanning was continuous except for when sample or buffer syringes 
were being changed at the beginning of each infusion/incubation phase.  General 
assay design was as described for previous multiplex assays wherein there is an 
initial buffer calibration/baseline measurement, infusion of the first bacterial cell 
sample, buffer wash/equilibration, infusion of alternate bacterial sample and a 
final wash/equilibration phase.  All assays were performed at room temperature 
with the flow cell resting on a plastic rack or mounted in a Styrofoam holder for 
thermal isolation from the bench top surface.  It is important to note that the flow 
cell is reliant upon compression of the MR chip for efficient sealing.  In many 
cases rings failed to respond or displayed extreme, erratic resonance shifts for 
no apparent reason.  It was determined post-assay that sensing microrings had 
failed, presumably as a result of compression when mounted in the flow cell.  
Therefore, averaging and reference subtraction were not performed, although 
reference ring values are provided where available. 
 
 
Results and Discussion 
 
The microring resonator chip design used in the present study consisted of five 
micro-ring resonators integrated on a single chip.  Each of the microring 
structures was vertically coupled to individual sets of input and output 
waveguides that were buried beneath the surface of the chip.  This design is 
ideal for biosensing applications as it prevents analyte-interaction with input and 
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output waveguides, thereby ensuring that any specific shift in the resonance 
spectrum resulted from analyte interactions with the micro-ring structure alone.  
The OSA-based reader system used in the present study for monitoring 
resonance wavelength had a noise level of ~1 picometer.  Assuming a detection 
resolution 3× the noise level, the minimum shift in wavelength that could be 
accurately detected would be ~3 pm.  Detection of binding of whole bacterial 
cells was achieved using this design, and species-specific binding of 2 enteric 
pathogens was demonstrated through the use of LPS-specific monoclonal 
antibody functionalization of individually-addressed rings, suggesting the utility of 
MR sensing methods in multiplex bacterial whole cell detection assays. 
  
E. coli Whole Cell Binding Experiments 
In order to demonstrate the ability to detect whole bacterial cell binding to 
microring resonator sensing devices, resonator chips were exposed to a high 
concentration (109 CFU) of E. coli O157:H7.  Resonance wavelength values 
associated with test rings functionalized with anti-E. coli antibody and control 
rings functionalized with non-E. coli antibody were similar during initial baseline 
collection in buffer and are shown in Figure 3.  When bacterial culture 
suspension was added, both treatment groups showed an initial rapid shift in 
resonance wavelength.  However, after a few scan cycles the resonance 
wavelength associated with the control group stabilized in comparison to the test 
rings, which displayed a continuous rise in wavelength over time.  Following 
transfer back to buffer the control group returned to values near those observed 
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during baseline data collection, while the test group remained elevated but 
stable. 
 
The rapid rise in resonance wavelength in both groups upon addition of culture 
was the result of a bulk refractive index shift caused by differing refractive index 
of equilibration buffer and the culture medium.  Microring resonators function as 
refractive index sensors and, as such, are extremely sensitive to changes in 
refractive index of the medium immediately surrounding the microring.  The 
composition of the bacterial test suspension is expected to have substantially 
different refractive index properties compared to buffer due to the presence of 
proteins and other components.  In addition, whole bacterial cells themselves can 
be expected to impart altered refractive index properties to the test suspension 
by virtue of their large size and relatively high mass.  Therefore, it is essential to 
return the test chip to equilibration buffer in order to determine the net change in 
resonance wavelength shift in test rings compared to control rings, and in turn 
determine if binding of whole bacterial cells to the microring surface has 
occurred.  The data in Figure 3 indicate bacterial cells did indeed bind to the test 
ring resulting in a large wavelength shift which was maintained following return to 
buffer.  Continuous wavelength scanning allowed visualization of bacterial 
binding over time as evidenced by the steady rise in resonance wavelength shift 
during bacterial culture incubation stage.  However, the bulk refractive index 
phenomenon can easily confound this observation.  Therefore, actual 
determination of cell binding should be determined after re-equilibration in buffer.  
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Parallel test rings treated in the same manner and subjected to SEM indicated 
binding of bacterial cells to the ring structure (Figure 4).  Cells were also bound to 
areas surrounding the ring due to the imprecise antibody application process 
which floods the epoxysilane-activated area surrounding the ring and in turn 
functionalizes these surfaces with antibody as well.  SEM comparison to control 
rings was dramatic, with no bacterial cells associated with these control ring 
structures. 
 
High Concentration Multiplex Assay 
The design of the MR chip allows independently-addressable sensing rings to be 
scanned continuously and independently over time.  Functionalization of 
individual microrings within an array, with antibodies specific for a particular 
bacterial species or even strains within a species, can facilitate multiplex assays 
capable of identifying one or more bacterial pathogens within a clinical sample 
simultaneously.  In order to determine the utility of microring resonators in 
multiplexed assays high concentration (109 CFU/ml) cultures of  S. Typhimurium 
or E. coli were tested sequentially while monitoring resonance wavelength peaks 
of microrings functionalized with species-specific antibody for species-specific 
bacterial binding to sensing surfaces.  The results of the assay are shown in 
Figure 5.  Addition of Salmonella culture resulted in a rapid wavelength shift in 
anti-Salmonella treated rings, with a comparatively small shift observed in anti-E. 
coli treated microrings as a result of bulk refractive index effects.  Interestingly, 
the bulk refractive index effect appeared to be of lower magnitude than observed 
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previously during single culture E. coli binding assays.  Following transfer to 
buffer the E. coli rings returned to baseline level while the S. Typhimurium rings 
remained elevated, indicating specific binding of Salmonella to cognate 
microrings.  Addition of E. coli culture caused a rapid upward shift in resonance 
wavelength in E. coli-specific rings with a small increase in S. Typhimurium rings.  
Following transfer to buffer the resonance wavelength of E. coli rings remained 
elevated relative to pre-E. coli values.  Wavelength values for Salmonella rings 
returned to levels similar to those observed during the intermediate buffer stage, 
indicating no binding of E. coli to Salmonella rings had occurred.  The net 
wavelength shift relative to baseline was less in E. coli rings compared to 
Salmonella rings.  The difference cannot readily be explained, although it may be 
a function of different antibody-antigen binding characteristics resulting in 
differing binding capacity or binding rate, or possibly due to degradation or loss of 
E. coli-specific antibody during the course of the assay.  Regardless, these 
results demonstrate the utility of application of microring arrays to a multiplex 
assay format for detection and identification for specific pathogens in samples 
containing high concentrations of bacteria.  The rapid increase at each sample 
addition step suggests the assay binding time could be shortened substantially 
with little likelihood of compromising final assay results. 
 
Low Concentration, Direct Application Multiplex Assay 
Previous experiments relied on the introduction of bacterial cell samples in a 
proportionately large assay volume (2 ml), which can be expected to seriously 
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impact speed of assay due to the need for mass transfer of analyte (cells) 
through a large volume to reach the sensing surface.  In an effort to improve 
mass transfer, assays were performed with low bacterial cell concentration 
suspensions (2000 cells in 20 µl) in PBS buffer applied directly to the MR chip 
surface.  Overall results were similar to those observed for high-concentration 
assays but data had sharper transitions due to transfer of the chip in and out of 
buffer (Figure 6).  Addition of Salmonella resulted in a positive shift in resonance 
wavelength in rings specific for that organism, while the E. coli rings showed a 
slight resonance shift in the opposite direction, a result which cannot be readily 
explained.  However, those assay rings returned to near baseline values when 
the chip was transferred back to PBS while the Salmonella-specific rings 
maintained the elevated resonance wavelength relative to baseline.  The addition 
of E. coli resulted in a positive bulk refractive index shift in both samples, and the 
resonance shift was maintained in E. coli microrings following transfer to buffer, 
and resonance shift was maintained in Salmonella rings as well.  As observed 
previously with high concentration assays the shift in resonance wavelength for 
E. coli-specific rings was of lower magnitude compared to Salmonella rings. 
 
Overall assay binding time at each step was approximately half that used for high 
concentration tube assays.  Net results were similar, but total shift in resonance 
wavelength was substantially less suggesting fewer cells, and hence less mass 
and lower RI, were bound to the sensing surface.  However, in most cases a 
peak was observed during binding suggesting some other unexplained factors 
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may be influencing binding capacity when samples are applied directly to the 
chip surface.  The surface of the chip is fairly hydrophobic, presumably due to 
unblocked epoxysilane groups, and samples applied to the surface tended to rest 
on the surface as drops with high surface tension.  Under these circumstances 
bacterial cells may be drawn to the perimeter of the drop and mass transfer may 
be hindered.  Influence of the unblocked surface on spontaneous covalent 
coupling of bacteria in the test sample to the chip surface via amine groups on 
the bacterial surface could not be determined.  Although this did not appear to 
affect high concentration assays there could be some effect at lower cell 
concentrations.  It is interesting to note that during binding, the apparent rate of 
cell binding which could be roughly deduced from the steepness of the binding 
curve was similar to that seen in high concentration assays.  Results from these 
assays demonstrate successful species-specific detection of whole bacterial cells 
at concentrations as low as 105 CFU/ml in a label-free assay system. 
 
Low Concentration Flow Cell Multiplex Assays 
In an effort to further enhance mass transport to the MR sensing surface, a 
microfluidic flow cell was incorporated into assays similar to those previously 
described.  Obtaining good multiplex assay data using the flow cell was 
challenging due to the loss of activity of some sensing rings after the MR chip 
was fitted to the flow cell apparatus.  An initial experiment employed a 105 
CFU/ml S. Typhimurium bacterial suspension to determine if cell-specific binding 
could be achieved at higher rates with high sensitivity.  The results showed a 
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rapid positive shift in resonance wavelength in both S. Typhimurium and E. coli 
microrings when cell suspension was applied (Figure 7).  Interestingly, the shift in 
the E. coli rings was almost 2-fold greater than in Salmonella microrings.  
However, when flow was transitioned back to buffer the resonance wavelength 
for both samples dropped to below-baseline levels.  Nonetheless, a net increase 
in resonance wavelength in Salmonella-specific microrings was observed 
compared to E. coli rings.  The unexpected wavelength shift characteristics could 
not be readily explained and may be the result of microfluidic effects associated 
with the flow cell.  Unfortunately, a functional reference ring was not available for 
this assay.  The overall response time based on steepness of the curve during 
binding suggested the flow cell substantially aided mass transport of bacteria to 
the cell surface. 
 
Further experiments were conducted to determine the utility of the flow cell 
device in multiplex assays.  In most cases it was difficult to obtain complete 
multiplex data due to inactivation of rings following fitment to the flow cell.  One 
experiment is shown in Figure 8, and in this case the reference ring is plotted 
rather than subtracted to illustrate flow cell characteristics, and only a single cell-
specific treatment ring was available for each group.  In this case, initial buffer 
flow caused an abrupt increase in reference and E. coli rings.  When flow was 
transitioned to a 104 CFU/ml suspension of E. coli, a bulk refractive index shift 
was noted in all samples.  Following transition to buffer there was a decrease in 
resonance wavelength for all microrings, with the E. coli ring higher than the 
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Salmonella ring.  Transition to a 104 CFU/ml suspension of Salmonella resulted 
in a positive wavelength shift in that treatment ring, but a decrease in reference 
and E. coli rings which continued into the buffer recovery phase.  The results 
following the first buffer recovery phase suggested an E. coli specific to that 
analyte.  However, initial noise in the PBS equilibration step, and in steps 
following E. coli binding and wash make overall results difficult to interpret.  
Although enhanced mass transport is expected in the flow cell apparatus due to 
much smaller sample volume, the steep slope observed at the onset of the 
bacterial presentation phase was also apparent in the reference ring, suggesting 
the observation may be an artifact of the overall bulk refractive index shift.  
Further experimentation using the flow cell device was not possible due to the 
potential damage to valuable sensing chips.  Nonetheless, the potential for 
improvement in response, as a result of lower assay volume and improved mass 
transport, is significant and warrants further investigation into improved flow cell 
design and testing. 
 
Overall performance of the system based on data for 1 x 105 CFU/ml in the low 
concentration, direct application experiment was about an order of magnitude 
more sensitive than previously reported for a Salmonella-specific electrochemical 
sensor (Yang et al., 2004) and the Love-wave surface acoustic wave (SAW) 
device described by Moll et al., (2007).  Linear bacterial detection range from 
102-108 CFU/ml have been demonstrated using a quartz crystal microbalance 
device (Huang and Cooper, 2006).  Linear range was not determined in this 
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study, but based on the data presented it appears the lower limit of detection 
range lies below 105 CFU/ml.  When compared to cantilever devices the 
performance was slightly better than deflection mode microcantilevers (Zhang 
and Ji, 2004), but was nowhere near the 500-700 CFU/ml claimed for millimeter 
sized cantilever devices (Zhu et al., 2007b; Campbell and Mutharasan, 2005b). 
 
When compared with the most popular optical platform, surface plasmon 
resonance (SPR), performance was equal or slightly better than the direct 
binding assay reported by Subramanian et al. (2006).  In their SPR system they 
reported sensitivity down to 104 CFU/ml using a sandwich binding assay.  The 
microring system described here operates on sensing refractive index changes 
as a result of bound mass, much the same as SPR functions.  It is reasonable to 
assume our system will have similar performance enhancement if a sandwich 
assay is used.  However, to date those experiments have not been performed 
and it is unclear exactly what performance enhancement could be achieved with 
this strategy.  The addition of another binding step would also add time and 
complexity to the assay which would not be desirable. 
 
The best SPR whole cell binding results reported to date claim sensitivity of 
around 25 CFU/ml (Waswa et al., 2006) which, if accurate, rival high-efficiency 
PCR for assay sensitivity.  Modifying our current system from a broad band light 
source and a scanning detector (the OSA) to a scanning light source and fixed 
detector is expected to provide at least an order of magnitude higher sensitivity.  
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This design would employ a tunable diode laser at the front end as the excitation 
source.  Such a reader design would have a much smaller form factor, and a 
portable microring sensor platform could be developed. 
 
In addition to flow cell design improvements and addition of a tunable diode 
laser, another important area for improvement revolves around application of 
antibody to the microring sensing surface.  As demonstrated by the SEM data in 
Figure 4b substantial area of the chip surface surrounding the ring becomes 
functionalized with antibody using the current spotting procedure.  Antibody not 
associated with the sensing surface competes for bacterial binding with that on 
the ring surface.  This can result in lack of sensitivity, which can be of great 
concern when attempting to maximize assay sensitivity.  Possible solutions are 
direct-writing of antibody on the surface of the microring.  One commercial 
example of this technology, dip pen nanolithography, involves the modification of 
an atomic force microscope to facilitate writing or “tapping” of antibody to precise 
regions on the sensing surface.  It is expected that precise functionalization 
methods will yield a significant gain in whole cell detection sensitivity, particularly 
when used in conjunction with a small assay chamber. 
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Conclusions 
 
The results of this study clearly demonstrate the ability to detect whole bacterial 
cells in a label-free assay format with species specificity, and suggest high utility 
for a microring array-based multiplexed bacterial detection system.  In this work, 
the organisms used constituted enteric pathogens of high importance both for 
their potential to cause serious disease and for their impact on food safety.  A 
sensitive, rapid and label-free multiplex assay to detect a range of pathogens in a 
sample is of great value.  Further efforts to develop the microring resonator 
platform for diagnostic and biomedical uses should be considered, with further 
optimization of low-volume flow cell devices and specific activation of sensing 
surfaces to maximize sensitivity and minimize competition for bacterial binding 
associated with non-sensing regions. 
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Figure 1.  Photograph of the five-ringed microring resonator chip.  A 
magnified view of the 5 rings with input and output ports are depicted in the 
drawing.  The input and output waveguides are “U” shaped with a single 
microring at the base of the U. 
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Figure 2.  Flow-cell for microring resonator assays.  Clockwise from left: 
Disassembled flow cell showing microchannels in cover, machined base and 
gasket defining flow channel; Base with chip and flow channel gasket; 
Assembled flow cell apparatus with connectorized MR sensing chip. 
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Figure 3.  Microring resonator detection of E. coli O157:H7.  Test: Microrings 
functionalized with antibody to E. coli O157:H7; Control: Microrings functionalized 
with non-E. coli-specific antibody.  Bacterial suspension used was E. coli 
O157:H7 at 109 CFU/ml. 
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Figure 4.  Scanning electron micrographs of bacteria bound to MR sensing 
chip.  E. coli cells are bound to ring surface functionalized with anti-E. coli 
antibody (Test, bottom) and not to non-E. coli antibody microrings (Control, top).  
Magnification: 2200X 
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Figure 5.  Sequential detection of S. Typhimurium and E. coli with 
microring resonator device.  Rings were functionalized with species-specific 
anti-LPS antibodies.  Results are averaged across 2 treatment microrings per 
group and corrected for reference.  
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Figure 6.  Multiplex detection of E. coli or S. Typhimurium on MR chips by 
direct application of sample to sensing surface.  Chips were transferred from 
buffer to humidity chamber during cell binding phases.  Data are averaged 
across 2 microrings per group and corrected for reference microring response. 
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Figure 7.  Detection of S. Typhimurium whole bacterial cells on MR chips in 
a flow cell apparatus.  Rings were functionalized with antibodies specific for E. 
coli or S. typhimurium LPS.  Reference ring data not available in this assay. 
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Figure 8.  Multiplex detection of E. coli or S. Typhimurium on microring 
resonators using a microfluidic flow cell apparatus. 
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CHAPTER VI 
CONCLUSION 
 
 
The results of the described research address the major points introduced at the 
beginning of this dissertation.  The ability to identify useful genomic sequences 
which can serve as genetic markers for nucleic acid-based detection protocols 
has been discussed.  Although the original goal of finding genomic markers 
associated with increased cytoxicity of the H1 isolate of C. piliforme was 
unsuccessful, the final result was highly useful in that new markers were 
identified.  These markers can be transitioned into assays for highly specific 
detection of this pathogen, particularly if a multiplex assay is performed.  It is 
anticipated that a system of this type will far outperform the current assays based 
on amplification of 16S ribosomal sequences. 
 
The ability to detect phenotypic markers associated with pathogenic organisms 
was shown, at least as proof-of-concept, in peptide displacement assays for 
MRSA, and the application of AFP to detection protocols has tremendous 
potential.  The major advantage of this type of assay is the detection of the 
protein product which is actually responsible for the phenotype, in this case 
 142 
methicillin resistance.  Protein detection assays of this nature are in some cases 
actually preferable to genetic tests because the result is not only detection of the 
marker, but also assurance that the protein is being expressed, creating the 
highly pathogenic phenotype. 
 
The application of label-free detection methods is the current area of most 
interest in diagnostic platforms, detection systems for medical and biodefense 
applications and animal health.  The application of optical microring resonator 
devices to whole bacterial cell detection in a multiplex assay design has not been 
previously reported.  The results presented here clearly demonstrate the utility of 
the platform, and provide credence for continued development into a fieldable 
device. 
 
Taken together, the data presented here give a broad view of detection schemes 
for pathogenic bacteria, including animal and human pathogens.  Further, both 
label-free and label-dependent assays were investigated, as were genetic and 
protein based assays. 
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APPENDIX 
 
 
 
Nucleotide Sequences and BLAST Homology Search Results for DNA 
Insert Sequences Generated By Clostridium Piliforme isolate H1 
Suppression Subtractive Hybridization
 164 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone A1: 
 
 
AGCGGCCGCCCGGGCAGGTCTCCAAGGCGGGTCCTTCGCTTTATTTTATTCTTTTTGTTT 
1.......10........20........30........40........50........60 
 
TTAATTGTTAAAGATTTGTTTTTTTGNTCGCTTGTTTGTTACCGCCCTCCGCACCACGCC 
........70........80........90.......100.......110.......120 
 
CT 
..
 165 
Computer Output of BLAST Homology Search for Insert Sequence A1: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 166 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone A2: 
 
 
TTAGGGCGNGGNAGCTGNAGGNANGTCATCATGTNTACCATTTCGNGNANTGCTCATGTA 
1.......10........20........30........40........50........60 
 
 
TGGGTTGCGACGATGNGCTACTTATAACGGTNTGNNATNACAGNAACTAAAGGTGTTTGC 
........70........80........90.......100.......110.......120 
 
 
TTATGTCATGTGNAGGTTNATGGNNCTACCCTCAACTTCTCATGTNCTGAGATTACCTGC 
.......130.......140.......150.......160.......170.......180 
 
 
CCGNGCGGTCG 
.......190.  
 167 
Computer Output of BLAST Homology Search for Insert Sequence A2: 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 168 
 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone A3: 
 
 
AGGGCGTGGTGCGGAGGGCGGTAATCTGGGTTAATAAAAGATTTAAGTCTAAAGATGCGT 
1.......10........20........30........40........50........60 
 
 
CCATTTCTAAAATATCTTTTTCCAGATATACCTAAAAATCATAAATCTCTTGACTATATA 
........70........80........90.......100.......110.......120 
 
 
TCAACAAATGTTATAGCAAATATACTTGGTCTTGGTTGGGCTGCAACTCCAGCTGGTATA 
.......130.......140.......150.......160.......170.......180 
 
 
AAAGCTATGGAAAGTTTACAGACGCTAAATTGATAAAAAAGATGAAGCCAGTAGATCACC 
.......190.......200.......210.......220.......230.......240 
 
 
TGCCCGGGCGGCCGCTCGA 
.......250......... 
 
 
 
 
 
 
 
 
 
 
 
 169 
Computer Output of BLAST Homology Search for Insert Sequence A3: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 170 
 
 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone B3: 
 
 
TGTAGCGTGAAGACGACAGAAGCCCTATAGTGAGTCGTATTACACCTGCCCGGGCGGCCG 
1.......10........20........30........40........50........60 
 
 
CTCGA 
..... 
 
 
 
 
 
 
 171 
Computer Output of BLAST Homology Search for Insert Sequence B3: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 172 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone C5: 
 
 
GCGCTGGTGCCGTGGCTCGNACCTGCGCCGGTGCGGTCGGGGCGCTACCGCCCGNTGTTC 
1.......10........20........30........40........50........60 
 
 
AAGNATCTACTTGCTGGCTGCTCGCGGCGGACTTCGTGATCCTGACCTGGGTCGGCGCCC 
........70........80........90.......100.......110.......120 
 
 
AGCAGACCACCTTCNCCTACGACTGGATCTCGCTCATCGCATCGGCCTACTGGTTCGCCT 
.......130.......140.......150.......160.......170.......180 
 
 
ACTTCCTGGTGATCCTGCCGATCCTCGGCGCGATCGAGAAGCCGGTGGCTCCGCCCGCGA 
.......190.......200.......210.......220.......230.......240 
 
 
CCCATCGAAGAAGACTTTCAACGCCCCACTACTCGCCGGCGACCCGGNGGCACGAAAACG 
.......250.......260.......270.......280.......290.......300 
 
 
GNTCGTGGCAGNAGTTATCTAAGAGGAGCATGGCGACCGTTCGGGGCCCCANTTTCGGCC 
.......310.......320.......330.......340.......350.......360 
 
 
CCTNTNGGGAGGNCGANTTTNCAATTTCNACTGGGCCGNNNGNTTTTAACAAACGN 
.......370.......380.......390.......400.......410...... 
 
 
 
 
 
 
 
 
 
 
 
 173 
Computer Output of BLAST Homology Search for Insert Sequence C5: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 174 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone C7: 
 
 
GAGGGCCGCCCGGGCAGGTACCTGCCTGTAATACGACTCACTATAGGGCTCGACCGCCCT 
1.......10........20........30........40........50........60 
 
 
CCGCACCACGCCCT 
........70.... 
 175 
Computer Output of BLAST Homology Search for Insert Sequence C7: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 176 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone D2: 
 
 
AGGGCGTGGTGCGGAGGACGGTGATCTGCATCTGCTAAATGGACTATACTTGCACCAGTA 
1.......10........20........30........40........50........60 
 
 
TTTATACCTATGTTTATGAAACTTGGTTATTCACCAGAGCTTACACAGGTTGCATATCGT 
........70........80........90.......100.......110.......120 
 
 
ATAGGTGACTACCTGCCCGGGCGGCCGCTCGA 
.......130.......140.......150.. 
 177 
Computer Output of BLAST Homology Search for Insert Sequence D2: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 178 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone D6: 
 
 
AGGGCGTGGTGCGGAGGGCGGTGATCATGTAGACCATTTCAGGAAATCTTAGGTATGGGT 
1.......10........20........30........40........50........60 
 
 
TGAGAGAGAAGATGTCCTACTTATAAGGCTGGTATTACAGAAACTAAAGCTGCTTGCTTA 
........70........80........90.......100.......110.......120 
 
 
TGTCATTGGAGGTTCATGAAACTACCTCAACTCTCATGTACTGAGATTACCTGCCCGGGC 
.......130.......140.......150.......160.......170.......180 
 
 
GGCCGCTCGA 
.......190
 179 
Computer Output of BLAST Homology Search for Insert Sequence D6: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 180 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone D7: 
 
 
TCGAGCGGCCGCCCGGGCAGGTCTCCAAGGCGGGTCCTTCGCTTTATTTTATTCTTTTTG 
1.......10........20........30........40........50........60 
 
 
TTTTTAATTGNTAAAGATTTGTTTTTTTGTTCGTTTGTTTGCTACCGTCCTCCGCACCAC 
........70........80........90.......100.......110.......120 
 
 
GCCCT 
..... 
 181 
Computer Output of BLAST Homology Search for Insert Sequence D7: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 182 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone E1: 
 
 
TCGAGCGGCCGCCCGGGCAGGTGATCAACCCTTAAAAACCAGCCATATTCTGCATCTGCA 
1.......10........20........30........40........50........60 
 
 
ACAACAAGTTTATTGCTACCATTTTGTATAGAATGGTGTGCAAGTGCCATGTCATCTGTA 
........70........80........90.......100.......110.......120 
 
 
ATAGGATTTAAGTCACAACCTATCTGCCATTCTAAGAAGAGTTTCTCCACCTGTTGTAAT 
.......130.......140.......150.......160.......170.......180 
 
 
ATTGGTTCCTAAAAGAAGCTTACCATCTTCCTGTCTATGAAATGATTACCGCCCTCCGCA 
.......190.......200.......210.......220.......230.......240 
 
 
CCACGCC 
....... 
 
 183 
Computer Output of BLAST Homology Search for Insert Sequence E1: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 184 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone E4: 
 
 
TCGAGCGGCCGCCCGGGCAGGTCTCCAAGGCGGGTCCTTCGCTTTATTTTATTCTTTTTG 
1.......10........20........30........40........50........60 
 
 
TTTTTAATTGTTAAAGATTTGTTTTTTTGTNCGTTTGTTTGCTACCGCCCTCCTCACCAC 
........70........80........90.......100.......110.......120 
 
 
GCCCT 
..... 
 185 
Computer Output of BLAST Homology Search for Insert Sequence E4: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 186 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone E5: 
 
 
AGGGCGTGGTGCGGAGGGCGGTATTCAAACATTGCACCAGGATTAGTATCAGCCATTTGT 
1.......10........20........30........40........50........60 
 
 
TGCTCAGTTGGTGATAAGCCTTTATCTATTAGGTCGATCACCTGCCCGGGCGGCCGCTCG 
........70........80........90.......100.......110.......120 
 
 
A 
. 
 
 187 
Computer Output of BLAST Homology Search for Insert Sequence E5: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 188 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone E6: 
 
 
AGGGCGTGGNGCGGAGGGCGGTAATCTGCAAAAAAAGGATNTTTAACATTATGACAAACT 
1.......10........20........30........40........50........60 
 
 
TGAAGCTATGACTTGNGNATGTTCTGTTGGACTTGNTATGGACTGCTGTACCTGGAGATA 
........70........80........90.......100.......110.......120 
 
 
CAGATGCACATACAATCTCTGCTATAATCGCAGATGAAATGGCTATTGGTANGATAAACA 
.......130.......140.......150.......160.......170.......180 
 
 
ATAAGACGACAGCAGTTAGAATAATACCTGTTATAGGGAAAAATGTTGGCGATATGGTTT 
.......190.......200.......210.......220.......230.......240 
 
 
CTTTTGGAGGATTATTAGGTGAGGCTCCAATAATGGCTGTAAATAAAGCCAAATGCTATG 
.......250.......260.......270.......280.......290.......300 
 
 
ATTTTATCAAGCGTGGNGGAAGAATACCTGCTNCTATTCATAGTTTTAAAAACTAATAGT 
.......310.......320.......330.......340.......350.......360 
 
 
NCATAACCTTATTGATTTAATCTGAATATATTAAAAAATAAGATTACCTGCCCGGGCGGC 
.......370.......380.......390.......400.......410.......420 
 
 
CCGCTCGA 
........  
 
 
 
 
 
 
 
 
 
 189 
Computer Output of BLAST Homology Search for Insert Sequence E6: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 190 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone F2: 
 
 
AGGGCGTGGTGCGGAGGGCGGTGAGGATTGTGATTGTGTGCTGTGACCGGCGGCAGCATC 
1.......10........20........30........40........50........60 
 
 
CGAGTGCTGATATTTATTAATTCAGCATATGAATATTTGACAACATGTTTGTATGGTTAC 
........70........80........90.......100.......110.......120 
 
 
AGCATACATGTAGAGGACCTGCCCGGGCGGCCGCTCGA 
.......130.......140.......150........ 
 
 
 
 
 191 
Computer Output of BLAST Homology Search for Insert Sequence F2: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 192 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone K4: 
 
 
GAGCGGCCGCCCGGGCAGGTAATCCCGTTATCCACCCTAGGGACCCTAAGGTCATATGCA 
1.......10........20........30........40........50........60 
 
 
ATAACAAATAATATAATAATATGGGTCACTAGCTCAGTTGGTAGAGCACCTGGACTTTTA 
........70........80........90.......100.......110.......120 
 
 
ATCCAGGTGTCCCGACCGCCCTCCGCACCACGCCCT 
.......130.......140.......150...... 
 
 193 
Computer Output of BLAST Homology Search for Insert Sequence K4: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 194 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone K5: 
 
 
TGTGCGTGAAGACGACAGAACGGAAGGCCCTATAGTGAGTCGTATTACAACGCCCTCCGC 
1.......10........20........30........40........50........60 
 
 
ACCACGCCCTGCNCAAATNCAAAAGNNNGNCNAAAACCCCGCCCAGGNC 
........70........80........90.......100.........  
 195 
Computer Output of BLAST Homology Search for Insert Sequence K5: 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
 196 
DNA Insert Sequence for C. Piliforme Suppression Subtractive 
Hybridization Clone K7: 
 
 
GNGNCATTACACNNCACGATGTNAGACCTGNNCTTCGCCTCGGNCGAGCACATCATGCGC 
1.......10........20........30........40........50........60 
 
 
AACGTGAACGGCGGCTTCATGCTGCGCTACCTGCATGCGAACGGNGCCTCGNTGTTCTTC 
........70........80........90.......100.......110.......120 
 
 
ATCGNGGNACTATCTGCACATCTTCCGAGGCACTCTACTACGGCAGCTNACAAGGCAGCC 
.......130.......140.......150.......160.......170.......180 
 
 
TGCGCAGAGGTCACCTGNATCGNGGGGATGCGTCATCTATCTNGCGATGATGGCNACCGG 
.......190.......200.......210.......220.......230.......240 
 
CTTNATGGGCTACGNGCTGCCGNGGGGCCAGATGTNCTTGTGGGGCNCCNCCGGGATCAC 
.......250.......260.......270.......280.......290.......300 
 
 
CGGCCTNTTCGGCGCGATCCCGGGCATCGGCCATTCNATCCAGACCTGGCTGCTCGGCGG 
.......310.......320.......330.......340.......350.......360 
 
 
CCCGGCGGTGGACAATGCCACGCTCAACCGGTTCTTCTCGCTGCACTACCTGCTGACCTT 
.......370.......380.......390.......400.......410.......420 
 
 
CGTGATCGCGGACGTCGAGGNCATGCACATNGTGGGCCTTCCACTCGACGGNCAACAACA 
.......430.......440.......450.......460.......470.......480 
 
 
ACCCGACCGGCGTCNAAGTGCGCCNNACCNCNAAGGCNGAAGCNCATAANGACACGGGCT 
.......490.......500.......510.......520.......530.......540 
 
 
CCCNTTNTGGCCNTANTNCATCATCAAGGACCNCGTTNNCCCTGGCCGAAACCTGCCGGG 
.......550.......560.......570.......580.......590.......600 
 
 
GGNTCTGGACCATCGGAGCGTTCNTCCCGANTACCNAGGNCACCCGGGCANCTNNNNNGT 
.......610.......620.......630.......640.......650.......660 
 
 
 197 
Computer Output of BLAST Homology Search for Insert Sequence K7: 
 
 
 
 
 
 
 
                                                                                                                                          Max    Total   Query         E       Max 
                                                                                                                                          score  score  coverage  value  ident.    
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